<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">Am J Epidemiol</journal-id><journal-id journal-id-type="hwp">amjepid</journal-id><journal-id journal-id-type="publisher-id">aje</journal-id><journal-title-group><journal-title>American Journal of Epidemiology</journal-title></journal-title-group><issn pub-type="ppub">0002-9262</issn><issn pub-type="epub">1476-6256</issn><publisher><publisher-name>Oxford University Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.1093/aje/kwp288</article-id><article-categories><subj-group subj-group-type="heading"><subject>Human Genome Epidemiology (Huge) Review</subject></subj-group></article-categories><title-group><article-title>Association Between the Ubiquitin Carboxyl-Terminal Esterase L1 Gene (<italic>UCHL1</italic>) S18Y Variant and Parkinson's Disease: A HuGE Review and Meta-Analysis</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Ragland</surname><given-names>Margaret</given-names></name></contrib><contrib contrib-type="author"><name><surname>Hutter</surname><given-names>Carolyn</given-names></name></contrib><contrib contrib-type="author"><name><surname>Zabetian</surname><given-names>Cyrus</given-names></name></contrib><contrib contrib-type="author"><name><surname>Edwards</surname><given-names>Karen</given-names></name><xref ref-type="corresp" rid="cor1">*</xref></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>Correspondence to Dr. Karen Edwards, University of Washington, Center for Genomics and Public Health, Box 354921, 6200 NE 74th Street, Building 29, Suite 250, Seattle, WA 98115 (e-mail: <email>keddy@u.washington.edu</email>).</corresp><fn><p><bold><italic>Editor's note:</italic></bold><italic>This paper is also available on the website of the Human Genome Epidemiology Network (<ext-link ext-link-type="uri" xlink:href="http://www.cdc.gov/genomics/hugenet/">http://www.cdc.gov/genomics/hugenet/</ext-link>).</italic></p></fn></author-notes><!--Fake ppub date generated by PMC from publisher pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><day>1</day><month>12</month><year>2009</year></pub-date><pub-date pub-type="epub"><day>28</day><month>10</month><year>2009</year></pub-date><pub-date pub-type="pmc-release"><day>28</day><month>10</month><year>2009</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. --><volume>170</volume><issue>11</issue><fpage>1344</fpage><lpage>1357</lpage><history><date date-type="received"><day>10</day><month>12</month><year>2008</year></date><date date-type="accepted"><day>13</day><month>8</month><year>2009</year></date></history><permissions><copyright-statement>American Journal of Epidemiology Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health 2009.</copyright-statement><copyright-year>2009</copyright-year><license license-type="open-access"><license-p><!--CREATIVE COMMONS-->This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/2.5/uk/">http://creativecommons.org/licenses/by-nc/2.5/uk/</ext-link>), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>The ubiquitin carboxyl-terminal esterase L1 gene, <italic>UCHL1</italic>, located on chromosome 4p14, has been studied as a potential candidate gene for Parkinson's disease risk. The authors conducted a Human Genome Epidemiology review and meta-analysis of published case-control studies of the <italic>UCHL1</italic> S18Y variant and Parkinson's disease in Asian and Caucasian samples. The meta-analysis of studies in populations of Asian ancestry showed a statistically significant association between the <italic>Y</italic> allele and reduced risk of Parkinson's disease under a recessive model (odds ratio (OR) for <italic>YY</italic> vs. <italic>SY</italic> + <italic>SS</italic> = 0.79, 95% confidence interval (CI): 0.67, 0.94; <italic>P</italic> = 0.006). For a dominant model, the association was not significant in Asian populations (OR for <italic>YY</italic> + <italic>SY</italic> vs. <italic>SS</italic> = 0.88, 95% CI: 0.68, 1.14; <italic>P</italic> = 0.33). For populations of European ancestry, the meta-analysis showed a significant association between the <italic>Y</italic> allele and decreased risk of Parkinson's disease under a dominant model (OR = 0.89, 95% CI: 0.81, 0.98; <italic>P</italic> = 0.02) but not under a recessive model (OR = 0.92, 95% CI: 0.66, 1.30; <italic>P</italic> = 0.65). Using the Venice criteria, developed by the Human Genome Epidemiology Network Working Group on the assessment of cumulative evidence, the authors concluded that moderate evidence exists for an association between the S18Y variant and Parkinson's disease.</p></abstract><kwd-group><kwd>case-control studies</kwd><kwd>epidemiology</kwd><kwd>genes</kwd><kwd>genetics</kwd><kwd>meta-analysis</kwd><kwd>Parkinson disease</kwd><kwd>review</kwd><kwd><italic>UCHL1</italic></kwd></kwd-group></article-meta></front><body><sec><title>GENE</title><p>The ubiquitin carboxyl-terminal esterase L1 gene, <italic>UCHL1</italic>, located on chromosome 4 (4p14), spans 11.5 kb and has 9 exons (Online Mendelian Inheritance in Man (OMIM); <ext-link ext-link-type="uri" xlink:href="www.ncbi.nlm.nih.gov/entrez/query.fcgi%3Fdb%3DOMIM">www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=OMIM</ext-link>)). UCHL1 protein (OMIM #191342) expression is specific to neurons, cells of the diffuse neuroendocrine system, testes, and ovaries (<xref ref-type="bibr" rid="bib1">1</xref>, <xref ref-type="bibr" rid="bib2">2</xref>). UCHL1 protein is especially abundant in the brain, constituting 1%&#x02013;2% of soluble brain protein (<xref ref-type="bibr" rid="bib3">3</xref>), and has been localized to Lewy bodies and other inclusion bodies characteristic of human neurodegenerative diseases (<xref ref-type="bibr" rid="bib4">4</xref>, <xref ref-type="bibr" rid="bib5">5</xref>).</p><p>The UCHL1 enzyme is involved in the ubiquitin proteasome system, a cellular pathway responsible for the degradation of misfolded and damaged proteins (<xref ref-type="bibr" rid="bib6">6</xref>). The ubiquitin proteasome system has been postulated to play an important role in the etiology of Parkinson's disease (for a review, refer to Lim and Tan (<xref ref-type="bibr" rid="bib7">7</xref>)). Specifically, UCHL1 is a member of the ubiquitin C-terminal hydrolase family of deubiquitinating enzymes, which catalyze the hydrolysis of polymeric ubiquitin chains (<xref ref-type="bibr" rid="bib8">8</xref>). In addition to a deubiquitination function, in vitro studies have shown that UCHL1 has dimerization-dependent ubiquitin ligase activity (<xref ref-type="bibr" rid="bib9">9</xref>). UCHL1-deficient mice, known as gracile axonal dystrophy mice, show neuronal loss in the spinal gracile tract and exhibit early development sensory ataxia and progressive motor ataxia (<xref ref-type="bibr" rid="bib10">10</xref>). In vitro studies of such mice show that UCHL1 noncovalently bonds to ubiquitin, thereby preventing ubiquitin degradation and maintaining the cellular pool of free ubiquitin (<xref ref-type="bibr" rid="bib11">11</xref>). Posttranslational regulation, such as monoubiquitination, is hypothesized to play an important role in UCHL1 protein function (<xref ref-type="bibr" rid="bib12">12</xref>).</p><p><italic>UCHL1</italic> has also been studied as a candidate gene for Huntington's disease (<xref ref-type="bibr" rid="bib1">1</xref>, <xref ref-type="bibr" rid="bib13">13</xref>, <xref ref-type="bibr" rid="bib14">14</xref>) and Alzheimer's disease (<xref ref-type="bibr" rid="bib3">3</xref>, <xref ref-type="bibr" rid="bib15">15</xref>), but evidence is not sufficient to support or refute an association. Additional studies have suggested that epigenetic changes altering <italic>UCHL1</italic> gene and protein expression may also serve as a marker of disease status or prognosis for several types of cancer (<xref ref-type="bibr" rid="bib2">2</xref>, <xref ref-type="bibr" rid="bib16">16</xref>, <xref ref-type="bibr" rid="bib17">17</xref>).</p></sec><sec><title>GENE VARIANTS</title><p>Two variants in the <italic>UCHL1</italic> gene have been examined in association with Parkinson's disease: I93M and S18Y (for a previous review, refer to Healy et al. (<xref ref-type="bibr" rid="bib1">1</xref>)). The I93M missense variant results from a cytosine-to-guanine transversion in codon 93 of exon 4. This variant was originally identified in 2 German siblings with familial Parkinson's disease (<xref ref-type="bibr" rid="bib18">18</xref>). The affected subjects had a form of disease that clinically resembled idiopathic Parkinson's disease; however, the father (a presumed carrier of the mutation) did not display the Parkinson's disease phenotype. In vitro studies indicate that this mutation results in partial loss of UCHL1 hydrolytic function (<xref ref-type="bibr" rid="bib18">18</xref>, <xref ref-type="bibr" rid="bib19">19</xref>). The S18Y variant results from a cytosine-to-adenine transversion at codon 18 in exon 3 (rs5030732). This variant was originally identified in a study screening Parkinson's disease patients for <italic>UCHL1</italic> polymorphisms (<xref ref-type="bibr" rid="bib20">20</xref>). In vitro studies provide evidence that the S18Y mutation results in decreased ligase activity and in slightly increased hydrolase activity compared with wild-type <italic>UCHL1</italic> (<xref ref-type="bibr" rid="bib9">9</xref>, <xref ref-type="bibr" rid="bib19">19</xref>).</p></sec><sec><title>GENE VARIANT FREQUENCY</title><p>Several studies have specifically screened for the I93M mutation in Parkinson's disease subjects (<xref ref-type="bibr" rid="bib21">21</xref>) and controls (<xref ref-type="bibr" rid="bib20">20</xref>, <xref ref-type="bibr" rid="bib22">22</xref>&#x02013;<xref ref-type="bibr" rid="bib24">24</xref>), including one relatively large sample of 229 German Parkinson's disease patients (<xref ref-type="bibr" rid="bib25">25</xref>). However, to date, there has been no documented occurrence of the I93M variant besides the 2 siblings in the original German Parkinson's disease family (<xref ref-type="bibr" rid="bib1">1</xref>).</p><p>Our literature search did not identify any studies that have conducted population-based surveys of S18Y frequency. Therefore, we summarized allele frequency based on control samples from case-control studies. The frequency of the <italic>Y</italic> allele varies across geographic regions (<xref ref-type="table" rid="tbl1">Table 1</xref>). The <italic>Y</italic> allele frequency is higher among individuals of Asian descent (46%&#x02013;61%) than among those of European descent (16%&#x02013;24%). To date, no studies have been known to examine the frequency of the <italic>UCHL1</italic> S18Y variant in other populations, such as Africans, Southeast Asians, Native Americans, Pacific Islanders, or Australian Aboriginals.</p><table-wrap id="tbl1" position="float"><label>Table 1.</label><caption><p>Worldwide Frequency of the <italic>UCHL1 Y</italic> Allele</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="center" rowspan="1" colspan="1">Geographic Region and Study (Reference No.)</td><td align="center" rowspan="1" colspan="1">Country</td><td align="center" rowspan="1" colspan="1">Ethnic Group</td><td align="center" rowspan="1" colspan="1">No.</td><td align="center" rowspan="1" colspan="1">Allele Frequency</td><td align="center" rowspan="1" colspan="1">95% Confidence Interval<xref ref-type="table-fn" rid="tblfn1">a</xref></td></tr></thead><tbody><tr><td rowspan="1" colspan="1">Asia</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Wang et al., 2002 (<xref ref-type="bibr" rid="bib98">98</xref>)</td><td rowspan="1" colspan="1">China</td><td rowspan="1" colspan="1">Asian</td><td align="char" char="." rowspan="1" colspan="1">160</td><td align="char" char="." rowspan="1" colspan="1">0.47</td><td align="char" char="." rowspan="1" colspan="1">0.41, 0.53</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Mizuta et al., 2006 (<xref ref-type="bibr" rid="bib106">106</xref>)</td><td rowspan="1" colspan="1">Japan</td><td rowspan="1" colspan="1">Asian</td><td align="char" char="." rowspan="1" colspan="1">736</td><td align="char" char="." rowspan="1" colspan="1">0.49</td><td align="char" char="." rowspan="1" colspan="1">0.47, 0.50</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Momose et al., 2002 (<xref ref-type="bibr" rid="bib107">107</xref>)</td><td rowspan="1" colspan="1">Japan</td><td rowspan="1" colspan="1">Asian</td><td align="char" char="." rowspan="1" colspan="1">248</td><td align="char" char="." rowspan="1" colspan="1">0.49</td><td align="char" char="." rowspan="1" colspan="1">0.45, 0.53</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Satoh and Kuroda, 2001 (<xref ref-type="bibr" rid="bib23">23</xref>)</td><td rowspan="1" colspan="1">Japan</td><td rowspan="1" colspan="1">Asian</td><td align="char" char="." rowspan="1" colspan="1">155</td><td align="char" char="." rowspan="1" colspan="1">0.54</td><td align="char" char="." rowspan="1" colspan="1">0.49, 0.59</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Zhang et al., 2000 (<xref ref-type="bibr" rid="bib108">108</xref>)</td><td rowspan="1" colspan="1">Japan</td><td rowspan="1" colspan="1">Asian</td><td align="char" char="." rowspan="1" colspan="1">160</td><td align="char" char="." rowspan="1" colspan="1">0.61<xref ref-type="table-fn" rid="tblfn2">b</xref></td><td align="char" char="." rowspan="1" colspan="1">0.56, 0.67</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Tan et al., 2006 (<xref ref-type="bibr" rid="bib109">109</xref>)</td><td rowspan="1" colspan="1">Singapore</td><td rowspan="1" colspan="1">Asian</td><td align="char" char="." rowspan="1" colspan="1">341</td><td align="char" char="." rowspan="1" colspan="1">0.46<xref ref-type="table-fn" rid="tblfn2">b</xref></td><td align="char" char="." rowspan="1" colspan="1">0.42, 0.50</td></tr><tr><td rowspan="1" colspan="1">Australia</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Mellick and Silburn, 2000 (<xref ref-type="bibr" rid="bib100">100</xref>)</td><td rowspan="1" colspan="1">Australia</td><td rowspan="1" colspan="1">Caucasian</td><td align="char" char="." rowspan="1" colspan="1">142</td><td align="char" char="." rowspan="1" colspan="1">0.16</td><td align="char" char="." rowspan="1" colspan="1">0.11, 0.20</td></tr><tr><td rowspan="1" colspan="1">Europe</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Elbaz et al., 2003 (<xref ref-type="bibr" rid="bib97">97</xref>)</td><td rowspan="1" colspan="1">France</td><td rowspan="1" colspan="1">Caucasian</td><td align="char" char="." rowspan="1" colspan="1">488</td><td align="char" char="." rowspan="1" colspan="1">0.19<xref ref-type="table-fn" rid="tblfn2">b</xref></td><td align="char" char="." rowspan="1" colspan="1">0.17, 0.22</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Levecque et al., 2001 (<xref ref-type="bibr" rid="bib101">101</xref>)</td><td rowspan="1" colspan="1">France</td><td rowspan="1" colspan="1">Caucasian</td><td align="char" char="." rowspan="1" colspan="1">93</td><td align="char" char="." rowspan="1" colspan="1">0.18</td><td align="char" char="." rowspan="1" colspan="1">0.13, 0.24</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Wintermeyer et al., 2000 (<xref ref-type="bibr" rid="bib25">25</xref>)</td><td rowspan="1" colspan="1">Germany</td><td rowspan="1" colspan="1">Caucasian</td><td align="char" char="." rowspan="1" colspan="1">200</td><td align="char" char="." rowspan="1" colspan="1">0.20</td><td align="char" char="." rowspan="1" colspan="1">0.16, 0.24</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Savettieri et al., 2001 (<xref ref-type="bibr" rid="bib102">102</xref>)</td><td rowspan="1" colspan="1">Italy</td><td rowspan="1" colspan="1">Caucasian</td><td align="char" char="." rowspan="1" colspan="1">165</td><td align="char" char="." rowspan="1" colspan="1">0.17</td><td align="char" char="." rowspan="1" colspan="1">0.13, 0.21</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Carmine Belin et al., 2007<xref ref-type="table-fn" rid="tblfn3">c</xref> (<xref ref-type="bibr" rid="bib99">99</xref>)</td><td rowspan="1" colspan="1">Sweden</td><td rowspan="1" colspan="1">Caucasian</td><td align="char" char="." rowspan="1" colspan="1">285</td><td align="char" char="." rowspan="1" colspan="1">0.17</td><td align="char" char="." rowspan="1" colspan="1">0.14, 0.20</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Healy et al., 2006 (<xref ref-type="bibr" rid="bib26">26</xref>)</td><td rowspan="1" colspan="1">United Kingdom</td><td rowspan="1" colspan="1">Caucasian</td><td align="char" char="." rowspan="1" colspan="1">1,482</td><td align="char" char="." rowspan="1" colspan="1">0.17<xref ref-type="table-fn" rid="tblfn2">b</xref></td><td align="char" char="." rowspan="1" colspan="1">0.15, 0.18</td></tr><tr><td rowspan="1" colspan="1">North America</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Facheris et al., 2005 (<xref ref-type="bibr" rid="bib92">92</xref>)</td><td rowspan="1" colspan="1">United States</td><td rowspan="1" colspan="1">Caucasian</td><td align="char" char="." rowspan="1" colspan="1">497</td><td align="char" char="." rowspan="1" colspan="1">0.19<xref ref-type="table-fn" rid="tblfn2">b</xref></td><td align="char" char="." rowspan="1" colspan="1">0.16, 0.21</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Hutter et al., 2008 (<xref ref-type="bibr" rid="bib95">95</xref>)</td><td rowspan="1" colspan="1">United States</td><td rowspan="1" colspan="1">Caucasian</td><td align="char" char="." rowspan="1" colspan="1">2,016</td><td align="char" char="." rowspan="1" colspan="1">0.19</td><td align="char" char="." rowspan="1" colspan="1">0.18, 0.20</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Maraganore et al., 1999 (<xref ref-type="bibr" rid="bib20">20</xref>)</td><td rowspan="1" colspan="1">United States</td><td rowspan="1" colspan="1">Caucasian</td><td align="char" char="." rowspan="1" colspan="1">110</td><td align="char" char="." rowspan="1" colspan="1">0.23</td><td align="char" char="." rowspan="1" colspan="1">0.18, 0.29</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Maraganore et al., 2004<xref ref-type="table-fn" rid="tblfn4">d</xref> (<xref ref-type="bibr" rid="bib91">91</xref>)</td><td rowspan="1" colspan="1">United States</td><td rowspan="1" colspan="1">Caucasian</td><td align="char" char="." rowspan="1" colspan="1">80</td><td align="char" char="." rowspan="1" colspan="1">0.24</td><td align="char" char="." rowspan="1" colspan="1">0.17, 0.31</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Zhang et al., 2000 (<xref ref-type="bibr" rid="bib108">108</xref>)</td><td rowspan="1" colspan="1">United States</td><td rowspan="1" colspan="1">Caucasian</td><td align="char" char="." rowspan="1" colspan="1">142</td><td align="char" char="." rowspan="1" colspan="1">0.19<xref ref-type="table-fn" rid="tblfn2">b</xref></td><td align="char" char="." rowspan="1" colspan="1">0.14, 0.25</td></tr></tbody></table><table-wrap-foot><fn><p>Abbreviation: <italic>UCHL1</italic>, ubiquitin carboxyl-terminal esterase L1 gene.</p></fn><fn id="tblfn1"><label>a</label><p>Calculated by using exact confidence intervals.</p></fn><fn id="tblfn2"><label>b</label><p>Allele frequencies were calculated from genotype frequencies in controls.</p></fn><fn id="tblfn3"><label>c</label><p>Incorrect frequency was presented in the initial publication; corrected frequency was obtained courtesy of the study author.</p></fn><fn id="tblfn4"><label>d</label><p>Excluding cases included in genotype counts in Maraganore et al. (<xref ref-type="bibr" rid="bib20">20</xref>).</p></fn></table-wrap-foot></table-wrap><p>Additional single nucleotide polymorphisms (SNPs) have been characterized through resequencing and the HapMap Project (<ext-link ext-link-type="uri" xlink:href="http://hapmap.ncbi.nlm.nih.gov/abouthapmap.html">http://hapmap.ncbi.nlm.nih.gov/abouthapmap.html</ext-link>). Healy et al. (<xref ref-type="bibr" rid="bib26">26</xref>) resequenced the <italic>UCHL1</italic> gene in 64 unrelated white individuals, identifying 5 SNPs with minor allele frequencies less than 5% and 23 SNPs with minor allele frequencies greater than 5%. They used information on linkage disequilibrium between these SNPs to determine that 3 SNPs were needed to tag common variation in the gene (<italic>r</italic><sup>2</sup> &#x0003e; 0.75) (<xref ref-type="bibr" rid="bib26">26</xref>). We examined the current HapMap data and found 10 SNPs with minor allele frequencies greater than 5% in each of the 4 HapMap populations (Yoruba from Ibadan, Nigeria; Japanese from Tokyo, Japan; Han Chinese from Beijing, China; and Utah residents of northern and western European ancestry) (<xref ref-type="bibr" rid="bib27">27</xref>). Using tagSNP methods based on pairwise linkage disequilibrium (<italic>r</italic><sup>2</sup> &#x02265; 0.80) (<xref ref-type="bibr" rid="bib28">28</xref>), we determined that 4 tagSNPs are needed to capture common variants (minor allele frequencies greater than 5%) for Utah residents of northern and western European ancestry, Japanese from Tokyo, and Han Chinese from Beijing and 5 tagSNPs for the Yoruba population from Ibadan. Aside from the paper by Healy et al., none of the other published studies have examined these variants in relation to Parkinson's disease.</p><p>The remainder of this review focuses on the S18Y variant only, because it is the best studied of the 2 variants. Until recently, the I93M variant had been identified in only 2 individuals, and a comprehensive tagSNP assessment of this gene had been performed by only Healy et al. (<xref ref-type="bibr" rid="bib26">26</xref>).</p></sec><sec><title>DISEASE</title><sec><title>Clinical and pathologic characteristics</title><p>Parkinson's disease is a progressive, neurodegenerative disorder clinically defined by a combination of cardinal motor features: tremor, rigidity, bradykinesia (slowness of movement), and postural instability (<xref ref-type="bibr" rid="bib29">29</xref>). The mainstay of treatment for motor symptoms is dopamine replacement therapy (e.g., levodopa), but current therapeutic strategies are only palliative and do not substantially alter the underlying degenerative process. A number of nonmotor features that are difficult to treat are common in Parkinson's disease, including cognitive dysfunction, sleep disorders, psychosis, depression, anosmia, and autonomic insufficiency (<xref ref-type="bibr" rid="bib30">30</xref>).</p><p>Pathologically, Parkinson's disease is characterized by a profound loss of dopaminergic neurons within the substantia nigra pars compacta and the presence of intraneuronal, cytoplasmic, eosinophilic inclusions called Lewy bodies (<xref ref-type="bibr" rid="bib31">31</xref>). Lewy bodies contain abnormal protein aggregates, and 2 of the most abundant constituents are &#x003b1;-synuclein and ubiquitin (<xref ref-type="bibr" rid="bib32">32</xref>, <xref ref-type="bibr" rid="bib33">33</xref>). Parkinson's disease becomes clinically evident when approximately 80% of striatal dopamine and 50% of nigral dopaminergic neurons are lost (<xref ref-type="bibr" rid="bib34">34</xref>).</p><p>Most clinicians and researchers consider neuropathologic diagnosis to be the &#x0201c;gold standard&#x0201d; for Parkinson's disease. Clinicopathologic series indicate that diagnostic accuracy based on clinical findings alone ranges from 75.6% to 98.6% (<xref ref-type="bibr" rid="bib35">35</xref>&#x02013;<xref ref-type="bibr" rid="bib39">39</xref>). Accuracy is highest when the diagnosis is made by a movement disorder specialist and is based on longitudinal assessments (<xref ref-type="bibr" rid="bib36">36</xref>). The clinical diagnostic criteria most commonly used in research are those of the United Kingdom Parkinson's Disease Society Brain Bank (<xref ref-type="bibr" rid="bib40">40</xref>).</p></sec><sec><title>Parkinson's disease prevalence</title><p>Parkinson's disease is the second most common neurodegenerative disease worldwide, after Alzheimer's disease. Parkinson's disease prevalence increases with age, so its burden is expected to increase with the aging US population (<xref ref-type="bibr" rid="bib41">41</xref>). Prevalence of Parkinson's disease is higher in men than in women (<xref ref-type="bibr" rid="bib42">42</xref>&#x02013;<xref ref-type="bibr" rid="bib44">44</xref>), although this finding is not observed in all studies. This gender difference is hypothesized to result from hormonal differences or differences in exposure to environmental risk factors (<xref ref-type="bibr" rid="bib45">45</xref>).</p><p>Studies of Parkinson's disease prevalence and incidence have been conducted in various populations worldwide (<xref ref-type="bibr" rid="bib41">41</xref>, <xref ref-type="bibr" rid="bib45">45</xref>&#x02013;<xref ref-type="bibr" rid="bib48">48</xref>). Data suggest that prevalence and incidence are similar across European and Asian populations. Even after accounting for differences in age structure, prevalence is lower in Africa than in Europe and Asia (<xref ref-type="bibr" rid="bib48">48</xref>, <xref ref-type="bibr" rid="bib49">49</xref>). However, studies have differed in terms of case definitions, methods of case ascertainment, and age categories examined. Therefore, these trends may simply reflect methodological differences between studies (<xref ref-type="bibr" rid="bib45">45</xref>, <xref ref-type="bibr" rid="bib50">50</xref>).</p></sec><sec><title>Genetic risk factors</title><p>Parkinson's disease is hypothesized to be a complex disease, with genetic and environmental contributions to its etiology. Evidence for genetic factors in Parkinson's disease was first mentioned in 1902, when William Gowers, a British neurologist, noted that approximately 15% of his Parkinson's disease patients reported an affected family member (<xref ref-type="bibr" rid="bib51">51</xref>). Although the genetic basis for Parkinson's disease is sometimes debated (<xref ref-type="bibr" rid="bib52">52</xref>), and results from twin studies are inconsistent (<xref ref-type="bibr" rid="bib53">53</xref>, <xref ref-type="bibr" rid="bib54">54</xref>), a large number of recent case-control studies have demonstrated that, compared with controls, Parkinson's disease subjects are 2&#x02013;14 times more likely to report a family history of the disease (<xref ref-type="bibr" rid="bib55">55</xref>).</p><p>Further evidence for the genetic basis of Parkinson's disease comes from the identification of causal genes in families in which Parkinson's disease is inherited as a simple Mendelian disorder, either in an autosomal dominant or an autosomal recessive pattern (for recent reviews, refer to Tan and Skipper (<xref ref-type="bibr" rid="bib56">56</xref>), Klein and Schlossmacher (<xref ref-type="bibr" rid="bib57">57</xref>), Belin and Westerlund (<xref ref-type="bibr" rid="bib58">58</xref>), and Lesage and Brice (<xref ref-type="bibr" rid="bib59">59</xref>)). <xref ref-type="table" rid="tbl2">Table 2</xref> provides details of regions identified as causal for monogenetic forms of Parkinson's disease. Mutations in these genes typically follow Mendelian patterns of inheritance within families. In some cases, the mutations result in disorders with clinical and/or pathologic distinctions from classic Parkinson's disease, most notably several monogenetic forms of the disease with an earlier age at onset.</p><table-wrap id="tbl2" position="float"><label>Table 2.</label><caption><p>PARK Regions That Have Been Linked to Parkinson's Disease in Family-based Studies</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="center" rowspan="1" colspan="1">Locus</td><td align="center" rowspan="1" colspan="1">Gene in Region Linked to Parkinson's Disease</td><td align="center" rowspan="1" colspan="1">Chromosomal Location</td><td align="center" rowspan="1" colspan="1">Form of Parkinson's Disease</td></tr></thead><tbody><tr><td rowspan="1" colspan="1">PARK1</td><td rowspan="1" colspan="1"><italic>SNCA</italic></td><td rowspan="1" colspan="1">4q21</td><td rowspan="1" colspan="1">Autosomal dominant</td></tr><tr><td rowspan="1" colspan="1">PARK2</td><td rowspan="1" colspan="1"><italic>PRKN</italic></td><td rowspan="1" colspan="1">6q25.2&#x02013;q27</td><td rowspan="1" colspan="1">Autosomal recessive (juvenile onset)</td></tr><tr><td rowspan="1" colspan="1">PARK3</td><td rowspan="1" colspan="1">&#x02014;<xref ref-type="table-fn" rid="tblfn5">a</xref></td><td rowspan="1" colspan="1">2p13</td><td rowspan="1" colspan="1">Autosomal dominant</td></tr><tr><td rowspan="1" colspan="1">PARK4</td><td rowspan="1" colspan="1"><italic>SNCA</italic></td><td rowspan="1" colspan="1">4p21</td><td rowspan="1" colspan="1">Autosomal dominant</td></tr><tr><td rowspan="1" colspan="1">PARK5</td><td rowspan="1" colspan="1">&#x02014;</td><td rowspan="1" colspan="1">4p14</td><td rowspan="1" colspan="1">Autosomal dominant and sporadic</td></tr><tr><td rowspan="1" colspan="1">PARK6</td><td rowspan="1" colspan="1"><italic>PINK1</italic></td><td rowspan="1" colspan="1">1p36</td><td rowspan="1" colspan="1">Autosomal recessive</td></tr><tr><td rowspan="1" colspan="1">PARK7</td><td rowspan="1" colspan="1"><italic>DJ-1</italic></td><td rowspan="1" colspan="1">1p36</td><td rowspan="1" colspan="1">Autosomal recessive and early onset</td></tr><tr><td rowspan="1" colspan="1">PARK8</td><td rowspan="1" colspan="1"><italic>LRRK2</italic></td><td rowspan="1" colspan="1">12q12</td><td rowspan="1" colspan="1">Autosomal dominant and sporadic</td></tr><tr><td rowspan="1" colspan="1">PARK9</td><td rowspan="1" colspan="1"><italic>ATP13A2</italic></td><td rowspan="1" colspan="1">1p36</td><td rowspan="1" colspan="1">Early onset</td></tr><tr><td rowspan="1" colspan="1">PARK10</td><td rowspan="1" colspan="1">&#x02014;</td><td rowspan="1" colspan="1">1p32</td><td rowspan="1" colspan="1">Idiopathic</td></tr><tr><td rowspan="1" colspan="1">PARK11</td><td rowspan="1" colspan="1">&#x02014;</td><td rowspan="1" colspan="1">2q36&#x02013;q37</td><td rowspan="1" colspan="1">Autosomal dominant and sporadic</td></tr><tr><td rowspan="1" colspan="1">PARK12</td><td rowspan="1" colspan="1">&#x02014;</td><td rowspan="1" colspan="1">X</td><td rowspan="1" colspan="1">Familial (mode of inheritance not known)</td></tr><tr><td rowspan="1" colspan="1">PARK13</td><td rowspan="1" colspan="1"><italic>HTRA2</italic></td><td rowspan="1" colspan="1">2p13</td><td rowspan="1" colspan="1">Idiopathic</td></tr></tbody></table><table-wrap-foot><fn><p>Abbreviations: <italic>ATP13A2</italic>, ATPase type 13A2 gene; <italic>DJ-1</italic>, oncogene DJ1; <italic>HTRA2</italic>, HtrA serine peptidase 2 gene; <italic>LRRK2</italic>, leucine-rich repeat kinase-2 gene; PARK, a region identified in linkage studies of Parkinson's disease; <italic>PINK1</italic>, PTEN-induced putative kinase 1 gene; <italic>PRKN</italic>, Parkinson's disease gene; <italic>SNCA</italic>, &#x003b1;-synuclein gene.</p></fn><fn id="tblfn5"><label>a</label><p>&#x02014;, not known.</p></fn></table-wrap-foot></table-wrap><p>Traditionally, regions identified in linkage studies of Parkinson's disease are initially given the designation PARK# (e.g., PARK1, PARK2, PARK3). Autosomal dominant forms of Parkinson's disease have been associated with mutations in the &#x003b1;-synuclein gene (<italic>SNCA</italic>) (PARK1 and PARK4 locus, chromosomal region 4q21) (<xref ref-type="bibr" rid="bib60">60</xref>) and the leucine-rich repeat kinase-2 gene (<italic>LRRK2</italic>) (PARK8 locus, 12p11.2&#x02013;q13.1) (<xref ref-type="bibr" rid="bib61">61</xref>, <xref ref-type="bibr" rid="bib62">62</xref>). Autosomal recessive forms have been associated with mutations in the <italic>parkin</italic> gene (PARK2, 6q25&#x02013;27) (<xref ref-type="bibr" rid="bib63">63</xref>), oncogene DJ1 (<italic>DJ-1</italic>) (PARK7, 1p36) (<xref ref-type="bibr" rid="bib64">64</xref>), the PTEN-induced putative kinase 1 gene (<italic>PINK1</italic>) (PARK6, 1p36) (<xref ref-type="bibr" rid="bib65">65</xref>), and the ATPase type 13A2 gene (<italic>ATP13A2</italic>) (PARK9, 1p36) (<xref ref-type="bibr" rid="bib66">66</xref>). Additional regions have been identified through linkage studies, including the PARK3 (2p13) (<xref ref-type="bibr" rid="bib67">67</xref>), PARK10 (1p32) (<xref ref-type="bibr" rid="bib68">68</xref>, <xref ref-type="bibr" rid="bib69">69</xref>), and PARK11 (2q36&#x02013;q37) (<xref ref-type="bibr" rid="bib70">70</xref>) regions. Specific causal genes have yet to be identified in these latter regions, and characterization of candidate genes remains an active area of research. For example, recent studies have nominated the sepiapterin reductase gene (<italic>SPR</italic>) as the most likely candidate in the PARK3 region (<xref ref-type="bibr" rid="bib71">71</xref>). The discovery of these causal mutations has provided important insights into biochemical pathways involved in the etiology of Parkinson's disease.</p><p>In addition, association studies have examined several other potential Parkinson's disease susceptibility genes identified on the basis of their function or by their role in other neurodegenerative diseases (<xref ref-type="bibr" rid="bib72">72</xref>). The PDGene website (<ext-link ext-link-type="uri" xlink:href="www.pdgene.org">www.pdgene.org</ext-link>), funded primarily by The Michael J. Fox Foundation for Parkinson's Research and the Alzheimer Research Forum, provides summaries of results from genetic epidemiologic studies of Parkinson's disease. More than 250 proposed Parkinson's disease susceptibility genes have been evaluated, and a number of potential pathways underlying Parkinson's disease etiology have been implicated, including those involved in mitochondrial stress, the ubiquitin proteasome system, and axon guidance. Of the genes summarized on PDGene, the strongest, most consistently replicated associations are seen for <italic>GBA</italic> (glucosidase, beta, acid), <italic>LRRK2</italic>, <italic>SNCA</italic>, and <italic>MAPT</italic> (microtubule-associated protein tau). More recently, additional candidate genes have been proposed based on the results of 3 genome-wide association studies (<xref ref-type="bibr" rid="bib73">73</xref>&#x02013;<xref ref-type="bibr" rid="bib75">75</xref>) and a genome-wide meta-analysis of 2 of these studies (<xref ref-type="bibr" rid="bib76">76</xref>). The results from the initial 2 genome-wide association studies have not been consistently replicated (<xref ref-type="bibr" rid="bib77">77</xref>&#x02013;<xref ref-type="bibr" rid="bib80">80</xref>). The most recent genome-wide association study focused on familial Parkinson's disease and supported associations for <italic>MAPT</italic> and <italic>SNCA</italic> as well as identifying a potential new susceptibility region near <italic>GAK</italic>/<italic>DGKQ</italic> (diacylglycerol kinase, theta/cyclin G-associated kinase) on chromosome 4 (<xref ref-type="bibr" rid="bib4">4</xref>, <xref ref-type="bibr" rid="bib75">75</xref>).</p></sec><sec><title>Environmental risk factors</title><p>A number of environmental exposures have been evaluated as risk factors for the development of Parkinson's disease (<xref ref-type="bibr" rid="bib45">45</xref>, <xref ref-type="bibr" rid="bib81">81</xref>), with the most commonly studied being smoking, caffeine or coffee consumption, alcohol consumption, and use of nonsteroidal antiinflammatory drugs. Each of these exposures has been shown to be associated with a decreased risk of Parkinson's disease, and the smoking association has been the most consistently replicated (<xref ref-type="bibr" rid="bib45">45</xref>, <xref ref-type="bibr" rid="bib82">82</xref>, <xref ref-type="bibr" rid="bib83">83</xref>). To date, there is no evidence for 2-way or 3-way interactions between smoking, coffee consumption, and use of over-the-counter nonsteroidal antiinflammatory drugs (<xref ref-type="bibr" rid="bib83">83</xref>). The effects are instead thought to be independent and cumulative, although evidence is limited (<xref ref-type="bibr" rid="bib83">83</xref>, <xref ref-type="bibr" rid="bib84">84</xref>).</p><p>Case-control studies have also examined exposures related to living in a rural setting, including the use of well water, farming, and pesticide exposure. The limited evidence available suggests a more than 2-fold increased risk of Parkinson's disease associated with pesticide exposure and a weaker association with well-water exposure, farming as an occupation, and generally living in a rural setting (<xref ref-type="bibr" rid="bib82">82</xref>, <xref ref-type="bibr" rid="bib85">85</xref>&#x02013;<xref ref-type="bibr" rid="bib88">88</xref>).</p><p>Other environmental risk factors possibly associated with Parkinson's disease include educational status, occupation, body mass index, dairy product consumption, and estrogen exposure, although results have been inconsistent. Higher levels of education have been shown to be associated with increased risk of Parkinson's disease, and physicians have been found to have higher rates of Parkinson's disease than nonphysicians (<xref ref-type="bibr" rid="bib89">89</xref>). Construction workers, miners, production workers, metal workers, and engineers have lower rates of Parkinson's disease than people in other occupations (<xref ref-type="bibr" rid="bib89">89</xref>). In addition, Parkinson's disease is typically less common in women than in men (<xref ref-type="bibr" rid="bib42">42</xref>). Evidence from animal models, as well as from humans, suggests that estrogens may protect the nigrostriatal dopaminergic pathway affected in Parkinson's disease (<xref ref-type="bibr" rid="bib90">90</xref>). Additional studies with large sample sizes must be completed to establish the role of these exposures in Parkinson's disease development.</p></sec></sec><sec><title>ASSOCIATIONS</title><p>Studies were selected through a computerized search of PubMed and the Web of Science by using the keywords &#x0201c;Parkinson disease,&#x0201d; &#x0201c;Parkinson's disease,&#x0201d; &#x0201c;Parkinsons disease,&#x0201d; &#x0201c;PD,&#x0201d; &#x0201c;<italic>UCHL1</italic>,&#x0201d; &#x0201c;UCH-L1,&#x0201d; and &#x0201c;UCHL-1.&#x0201d; We included papers published through July 1, 2008. References in the papers found via the computerized search were examined to identify additional studies. Studies were included if they provided original data on the association of Parkinson's disease with <italic>UCHL1</italic>, were published in peer-reviewed journals, and used either a case-control or a family-based design. Two of the authors (M. R. and C. H.) independently performed this search, reviewed all studies, and abstracted data using a standardized form.</p><p>Some papers contained discrepancies between the sample sizes and the genotype/allele counts presented. When discrepancies were found, we either referred to updated data in existing meta-analyses (<xref ref-type="bibr" rid="bib26">26</xref>, <xref ref-type="bibr" rid="bib91">91</xref>) or contacted the corresponding author to resolve the discrepancy. To date, studies of the S18Y variant and Parkinson's disease have been performed exclusively in populations of European or Asian descent. One study was primarily family based (<xref ref-type="bibr" rid="bib92">92</xref>), whereas the remainder used case-control designs. For the study that was both family based and case-control, we present only the case-control results in our tables and meta-analysis. In addition to ethnic group differences, other important differences between studies were the control selection methods and the covariates used as adjustment factors in the analysis. Most studies adjusted for covariates, including age and sex, and covariates included in the model do not appear to account for differences in results.</p><p>We conducted a meta-analysis to evaluate the relation between <italic>UCHL1</italic> S18Y and Parkinson's disease. Because of allele frequency differences between ethnic groups and potential population stratification, we performed the meta-analysis separately for studies of subjects of European ancestry (11 studies) and Asian ancestry (5 studies). Currently, there is no conclusive evidence for the genetic model underlying the potential relation between S18Y genotype and Parkinson's disease; therefore, we examined a dominant, recessive, and additive model of inheritance for the minor (<italic>Y</italic>) allele. The overall odds ratio, 95% confidence interval, and <italic>P</italic> value were calculated by using a random-effects model (<xref ref-type="bibr" rid="bib93">93</xref>). The random-effects (DerSimonian-Laird) model accounts for between-study heterogeneity. Forest plots were used to display the results from individual studies, as well as summary results. The significance of between-study heterogeneity was evaluated by using Cochran's <italic>Q</italic> statistic. If the <italic>P</italic> value was less than 0.10, the heterogeneity was considered statistically significant. We also quantified heterogeneity using the <italic>I</italic><sup>2</sup> metric (<xref ref-type="bibr" rid="bib94">94</xref>). <italic>I</italic><sup>2</sup> takes values between 0% and 100%; higher values indicate higher levels of heterogeneity.</p><p>Pearson's &#x003c7;<sup>2</sup> was used to evaluate Hardy-Weinberg equilibrium in the control group for all studies. Samples with <italic>P</italic> values below 0.05 were considered out of Hardy-Weinberg disequilibrium and were excluded from the meta-analysis. One study (Satoh and Kuroda (<xref ref-type="bibr" rid="bib23">23</xref>)) was out of Hardy-Weinberg equilibrium in the control group (<italic>P</italic> = 0.01) and was excluded from the primary meta-analysis. For sensitivity analysis, we repeated the meta-analysis including the Satoh and Kuroda study. We also repeated the analysis excluding the subset of the Maraganore et al. study (<xref ref-type="bibr" rid="bib20">20</xref>) included in their initial 1999 report and excluding the study by Facheris et al. (<xref ref-type="bibr" rid="bib92">92</xref>) because it was primarily family based. All analyses were performed by using Stata software, version 9.0 (Stata Corporation, College Station, Texas).</p></sec><sec sec-type="results"><title>RESULTS</title><p><xref ref-type="table" rid="tbl3">Table 3</xref> summarizes the evidence for an association between <italic>UCHL1</italic> S18Y and Parkinson's disease from 6 case-control studies of subjects of Asian ancestry and 12 case-control studies of subjects of European ancestry. The table includes genotype counts, a summary of the primary finding as reported in the original publication, and a calculation of the crude odds ratios for the comparison of <italic>SY</italic> versus <italic>SS</italic> and <italic>YY</italic> versus <italic>SS</italic>. Although the results are not completely consistent across studies, the overall results show little evidence for an association with the S18Y variant. With the exception of the 2 recent studies by Healy et al. (<xref ref-type="bibr" rid="bib26">26</xref>) (1,536 cases and 1,487 controls) and Hutter et al. (<xref ref-type="bibr" rid="bib95">95</xref>) (1,757 cases and 2,016 controls), the sample sizes for these studies were relatively small (median sample size: 169 cases and 165 controls).</p><table-wrap id="tbl3" position="float"><label>Table 3.</label><caption><p>Genotype Counts From Case-Control Studies Evaluating the Association Between the <italic>UCHL1</italic> S18Y Variant and Parkinson's Disease Published Through July 1, 2008</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="center" rowspan="1" colspan="1">Country and Study (Reference No.)</td><td align="center" rowspan="1" colspan="1">Genotype</td><td align="center" rowspan="1" colspan="1">No. of Cases</td><td align="center" rowspan="1" colspan="1">No. of Controls</td><td align="center" rowspan="1" colspan="1">Recalculated Odds Ratio<xref ref-type="table-fn" rid="tblfn6">a</xref></td><td align="center" rowspan="1" colspan="1">95% Confidence Interval</td><td align="center" rowspan="1" colspan="1"><italic>P</italic> Value</td></tr></thead><tbody><tr><td align="center" colspan="7" rowspan="1"><italic>Asia</italic></td></tr><tr><td rowspan="1" colspan="1">China</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="3" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Wang et al., 2002 (<xref ref-type="bibr" rid="bib98">98</xref>)</td><td rowspan="1" colspan="1"><italic>SS</italic></td><td align="char" char="." rowspan="1" colspan="1">40</td><td align="char" char="." rowspan="1" colspan="1">45</td><td align="char" char="." rowspan="1" colspan="1">1.00</td><td rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1">0.802</td></tr><tr><td rowspan="1" colspan="1"><italic>SY</italic></td><td align="char" char="." rowspan="1" colspan="1">82</td><td align="char" char="." rowspan="1" colspan="1">80</td><td align="char" char="." rowspan="1" colspan="1">1.15</td><td align="char" char="." rowspan="1" colspan="1">0.66, 2.02</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>YY</italic></td><td align="char" char="." rowspan="1" colspan="1">38</td><td align="char" char="." rowspan="1" colspan="1">35</td><td align="char" char="." rowspan="1" colspan="1">1.22</td><td align="char" char="." rowspan="1" colspan="1">0.62, 2.4</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Japan</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="3" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Mizuta et al., 2006<xref ref-type="table-fn" rid="tblfn7">b</xref> (<xref ref-type="bibr" rid="bib106">106</xref>)</td><td rowspan="1" colspan="1"><italic>SS</italic></td><td align="char" char="." rowspan="1" colspan="1">149</td><td align="char" char="." rowspan="1" colspan="1">199</td><td align="char" char="." rowspan="1" colspan="1">1.00</td><td rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1">0.165</td></tr><tr><td rowspan="1" colspan="1"><italic>SY</italic></td><td align="char" char="." rowspan="1" colspan="1">340</td><td align="char" char="." rowspan="1" colspan="1">366</td><td align="char" char="." rowspan="1" colspan="1">1.22</td><td align="char" char="." rowspan="1" colspan="1">0.94, 1.59</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>YY</italic></td><td align="char" char="." rowspan="1" colspan="1">124</td><td align="char" char="." rowspan="1" colspan="1">171</td><td align="char" char="." rowspan="1" colspan="1">1.00</td><td align="char" char="." rowspan="1" colspan="1">0.72, 1.37</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="3" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Momose et al., 2002 (<xref ref-type="bibr" rid="bib107">107</xref>)</td><td rowspan="1" colspan="1"><italic>SS</italic></td><td align="char" char="." rowspan="1" colspan="1">71</td><td align="char" char="." rowspan="1" colspan="1">61</td><td align="char" char="." rowspan="1" colspan="1">1.00</td><td rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1">0.136</td></tr><tr><td rowspan="1" colspan="1"><italic>SY</italic></td><td align="char" char="." rowspan="1" colspan="1">119</td><td align="char" char="." rowspan="1" colspan="1">122</td><td align="char" char="." rowspan="1" colspan="1">0.84</td><td align="char" char="." rowspan="1" colspan="1">0.54, 1.31</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>YY</italic></td><td align="char" char="." rowspan="1" colspan="1">40</td><td align="char" char="." rowspan="1" colspan="1">65</td><td align="char" char="." rowspan="1" colspan="1">0.53</td><td align="char" char="." rowspan="1" colspan="1">0.30, 0.92</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="3" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Satoh and Kuroda, 2001 (<xref ref-type="bibr" rid="bib23">23</xref>)</td><td rowspan="1" colspan="1"><italic>SS</italic></td><td align="char" char="." rowspan="1" colspan="1">28</td><td align="char" char="." rowspan="1" colspan="1">41</td><td align="char" char="." rowspan="1" colspan="1">1.00</td><td rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1">0.011</td></tr><tr><td rowspan="1" colspan="1"><italic>SY</italic></td><td align="char" char="." rowspan="1" colspan="1">35</td><td align="char" char="." rowspan="1" colspan="1">62</td><td align="char" char="." rowspan="1" colspan="1">0.83</td><td align="char" char="." rowspan="1" colspan="1">0.42, 1.64</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>YY</italic></td><td align="char" char="." rowspan="1" colspan="1">11</td><td align="char" char="." rowspan="1" colspan="1">52</td><td align="char" char="." rowspan="1" colspan="1">0.31</td><td align="char" char="." rowspan="1" colspan="1">0.12, 0.74</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="3" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Zhang et al., 2000 (<xref ref-type="bibr" rid="bib108">108</xref>)</td><td rowspan="1" colspan="1"><italic>SS</italic></td><td align="char" char="." rowspan="1" colspan="1">52</td><td align="char" char="." rowspan="1" colspan="1">35</td><td align="char" char="." rowspan="1" colspan="1">1.00</td><td rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1">0.095</td></tr><tr><td rowspan="1" colspan="1"><italic>SY</italic></td><td align="char" char="." rowspan="1" colspan="1">77</td><td align="char" char="." rowspan="1" colspan="1">86</td><td align="char" char="." rowspan="1" colspan="1">0.60</td><td align="char" char="." rowspan="1" colspan="1">0.34, 1.05</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>YY</italic></td><td align="char" char="." rowspan="1" colspan="1">31</td><td align="char" char="." rowspan="1" colspan="1">39</td><td align="char" char="." rowspan="1" colspan="1">0.54</td><td align="char" char="." rowspan="1" colspan="1">0.27, 1.06</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Singapore</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="3" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Tan et al., 2006 (<xref ref-type="bibr" rid="bib109">109</xref>)</td><td rowspan="1" colspan="1"><italic>SS</italic></td><td align="char" char="." rowspan="1" colspan="1">93</td><td align="char" char="." rowspan="1" colspan="1">71</td><td align="char" char="." rowspan="1" colspan="1">1.00</td><td rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1">0.202</td></tr><tr><td rowspan="1" colspan="1"><italic>SY</italic></td><td align="char" char="." rowspan="1" colspan="1">194</td><td align="char" char="." rowspan="1" colspan="1">172</td><td align="char" char="." rowspan="1" colspan="1">0.86</td><td align="char" char="." rowspan="1" colspan="1">0.58, 1.27</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>YY</italic></td><td align="char" char="." rowspan="1" colspan="1">88</td><td align="char" char="." rowspan="1" colspan="1">98</td><td align="char" char="." rowspan="1" colspan="1">0.69</td><td align="char" char="." rowspan="1" colspan="1">0.44, 1.07</td><td rowspan="1" colspan="1"/></tr><tr><td align="center" colspan="7" rowspan="1"><italic>Australia</italic></td></tr><tr><td rowspan="1" colspan="1">Australia</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="3" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Mellick and Silburn, 2000 (<xref ref-type="bibr" rid="bib100">100</xref>)</td><td rowspan="1" colspan="1"><italic>SS</italic></td><td align="char" char="." rowspan="1" colspan="1">100</td><td align="char" char="." rowspan="1" colspan="1">101</td><td align="char" char="." rowspan="1" colspan="1">1.00</td><td rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1">0.188</td></tr><tr><td rowspan="1" colspan="1"><italic>SY</italic></td><td align="char" char="." rowspan="1" colspan="1">33</td><td align="char" char="." rowspan="1" colspan="1">38</td><td align="char" char="." rowspan="1" colspan="1">0.88</td><td align="char" char="." rowspan="1" colspan="1">0.49, 1.56</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>YY</italic></td><td align="char" char="." rowspan="1" colspan="1">9</td><td align="char" char="." rowspan="1" colspan="1">3</td><td align="char" char="." rowspan="1" colspan="1">3.03</td><td align="char" char="." rowspan="1" colspan="1">0.72, 17.81</td><td rowspan="1" colspan="1"/></tr><tr><td align="center" colspan="7" rowspan="1"><italic>Europe</italic></td></tr><tr><td rowspan="1" colspan="1">France</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="3" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Elbaz et al., 2003 (<xref ref-type="bibr" rid="bib97">97</xref>)</td><td rowspan="1" colspan="1"><italic>SS</italic></td><td align="char" char="." rowspan="1" colspan="1">139</td><td align="char" char="." rowspan="1" colspan="1">323</td><td align="char" char="." rowspan="1" colspan="1">1.00</td><td rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1">0.182</td></tr><tr><td rowspan="1" colspan="1"><italic>SY</italic></td><td align="char" char="." rowspan="1" colspan="1">67</td><td align="char" char="." rowspan="1" colspan="1">145</td><td align="char" char="." rowspan="1" colspan="1">1.07</td><td align="char" char="." rowspan="1" colspan="1">0.74, 1.55</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>YY</italic></td><td align="char" char="." rowspan="1" colspan="1">3</td><td align="char" char="." rowspan="1" colspan="1">20</td><td align="char" char="." rowspan="1" colspan="1">0.35</td><td align="char" char="." rowspan="1" colspan="1">0.07, 1.21</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="3" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Levecque et al., 2001 (<xref ref-type="bibr" rid="bib101">101</xref>)</td><td rowspan="1" colspan="1"><italic>SS</italic></td><td align="char" char="." rowspan="1" colspan="1">76</td><td align="char" char="." rowspan="1" colspan="1">64</td><td align="char" char="." rowspan="1" colspan="1">1.00</td><td rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1">0.852</td></tr><tr><td rowspan="1" colspan="1"><italic>SY</italic></td><td align="char" char="." rowspan="1" colspan="1">33</td><td align="char" char="." rowspan="1" colspan="1">24</td><td align="char" char="." rowspan="1" colspan="1">1.16</td><td align="char" char="." rowspan="1" colspan="1">0.59, 2.27</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>YY</italic></td><td align="char" char="." rowspan="1" colspan="1">5<xref ref-type="table-fn" rid="tblfn8">c</xref></td><td align="char" char="." rowspan="1" colspan="1">5</td><td align="char" char="." rowspan="1" colspan="1">0.84</td><td align="char" char="." rowspan="1" colspan="1">0.19, 3.84</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Germany</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="3" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Wintermeyer et al., 2000 (<xref ref-type="bibr" rid="bib25">25</xref>)</td><td rowspan="1" colspan="1"><italic>SS</italic></td><td align="char" char="." rowspan="1" colspan="1">169</td><td align="char" char="." rowspan="1" colspan="1">128</td><td align="char" char="." rowspan="1" colspan="1">1.00</td><td rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1">0.059</td></tr><tr><td rowspan="1" colspan="1"><italic>SY</italic></td><td align="char" char="." rowspan="1" colspan="1">51</td><td align="char" char="." rowspan="1" colspan="1">65</td><td align="char" char="." rowspan="1" colspan="1">0.59</td><td align="char" char="." rowspan="1" colspan="1">0.38, 0.94</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>YY</italic></td><td align="char" char="." rowspan="1" colspan="1">9</td><td align="char" char="." rowspan="1" colspan="1">7</td><td align="char" char="." rowspan="1" colspan="1">0.97</td><td align="char" char="." rowspan="1" colspan="1">0.31, 3.17</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Italy</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="3" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Savettieri et al., 2001 (<xref ref-type="bibr" rid="bib102">102</xref>)</td><td rowspan="1" colspan="1"><italic>SS</italic></td><td align="char" char="." rowspan="1" colspan="1">118</td><td align="char" char="." rowspan="1" colspan="1">115</td><td align="char" char="." rowspan="1" colspan="1">1.00</td><td rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1">0.999</td></tr><tr><td rowspan="1" colspan="1"><italic>SY</italic></td><td align="char" char="." rowspan="1" colspan="1">46</td><td align="char" char="." rowspan="1" colspan="1">45</td><td align="char" char="." rowspan="1" colspan="1">1.00</td><td align="char" char="," rowspan="1" colspan="1">0.60, 1.67</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>YY</italic></td><td align="char" char="." rowspan="1" colspan="1">5</td><td align="char" char="." rowspan="1" colspan="1">5</td><td align="char" char="." rowspan="1" colspan="1">0.97</td><td align="char" char="," rowspan="1" colspan="1">0.22, 4.36</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Sweden</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="3" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Carmine Belin et al., 2007<xref ref-type="table-fn" rid="tblfn9">d</xref> (<xref ref-type="bibr" rid="bib99">99</xref>)</td><td rowspan="1" colspan="1"><italic>SS</italic></td><td align="char" char="." rowspan="1" colspan="1">218</td><td align="char" char="." rowspan="1" colspan="1">191</td><td align="char" char="." rowspan="1" colspan="1">1.00</td><td rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1">0.216</td></tr><tr><td rowspan="1" colspan="1"><italic>SY</italic></td><td align="char" char="." rowspan="1" colspan="1">74</td><td align="char" char="." rowspan="1" colspan="1">89</td><td align="char" char="." rowspan="1" colspan="1">0.73</td><td align="char" char="," rowspan="1" colspan="1">0.50, 1.07</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>YY</italic></td><td align="char" char="." rowspan="1" colspan="1">4</td><td align="char" char="." rowspan="1" colspan="1">5</td><td align="char" char="." rowspan="1" colspan="1">0.70</td><td align="char" char="," rowspan="1" colspan="1">0.14, 3.31</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">United Kingdom</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="3" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Healy et al., 2006 (<xref ref-type="bibr" rid="bib26">26</xref>)</td><td rowspan="1" colspan="1"><italic>SS</italic></td><td align="char" char="." rowspan="1" colspan="1">1,074</td><td align="char" char="." rowspan="1" colspan="1">1,028</td><td align="char" char="." rowspan="1" colspan="1">1.00</td><td rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1">0.54</td></tr><tr><td rowspan="1" colspan="1"><italic>SY</italic></td><td align="char" char="." rowspan="1" colspan="1">409</td><td align="char" char="." rowspan="1" colspan="1">418</td><td align="char" char="." rowspan="1" colspan="1">0.94</td><td align="char" char="," rowspan="1" colspan="1">0.79, 1.1</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>YY</italic></td><td align="char" char="." rowspan="1" colspan="1">44</td><td align="char" char="." rowspan="1" colspan="1">36</td><td align="char" char="." rowspan="1" colspan="1">1.17</td><td align="char" char="," rowspan="1" colspan="1">0.73, 1.89</td><td rowspan="1" colspan="1"/></tr><tr><td align="center" colspan="7" rowspan="1"><italic>North America</italic></td></tr><tr><td rowspan="1" colspan="1">United States</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="3" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Facheris et al., 2005 (<xref ref-type="bibr" rid="bib92">92</xref>)</td><td rowspan="1" colspan="1"><italic>SS</italic></td><td align="char" char="." rowspan="1" colspan="1">44</td><td align="char" char="." rowspan="1" colspan="1">41</td><td align="char" char="." rowspan="1" colspan="1">1.00</td><td rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1">0.044</td></tr><tr><td rowspan="1" colspan="1"><italic>SY</italic></td><td align="char" char="." rowspan="1" colspan="1">26</td><td align="char" char="." rowspan="1" colspan="1">23</td><td align="char" char="." rowspan="1" colspan="1">1.05</td><td align="char" char="," rowspan="1" colspan="1">0.49, 2.26</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>YY</italic></td><td align="char" char="." rowspan="1" colspan="1">0</td><td align="char" char="." rowspan="1" colspan="1">6</td><td align="char" char="." rowspan="1" colspan="1">0</td><td align="char" char="," rowspan="1" colspan="1">0, 0.62</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="3" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Hutter et al., 2008 (<xref ref-type="bibr" rid="bib95">95</xref>)</td><td rowspan="1" colspan="1"><italic>SS</italic></td><td align="char" char="." rowspan="1" colspan="1">1,191</td><td align="char" char="." rowspan="1" colspan="1">1,324</td><td align="char" char="." rowspan="1" colspan="1">1.00</td><td rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1">0.388</td></tr><tr><td rowspan="1" colspan="1"><italic>SY</italic></td><td align="char" char="." rowspan="1" colspan="1">509</td><td align="char" char="." rowspan="1" colspan="1">621</td><td align="char" char="." rowspan="1" colspan="1">0.91</td><td align="char" char="," rowspan="1" colspan="1">0.79, 1.95</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>YY</italic></td><td align="char" char="." rowspan="1" colspan="1">57</td><td align="char" char="." rowspan="1" colspan="1">71</td><td align="char" char="." rowspan="1" colspan="1">0.89</td><td align="char" char="," rowspan="1" colspan="1">0.61, 1.29</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="3" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Maraganore et al., 1999<xref ref-type="table-fn" rid="tblfn8">c</xref> (<xref ref-type="bibr" rid="bib20">20</xref>)</td><td rowspan="1" colspan="1"><italic>SS</italic></td><td align="char" char="." rowspan="1" colspan="1">95</td><td align="char" char="." rowspan="1" colspan="1">64</td><td align="char" char="." rowspan="1" colspan="1">1.00</td><td rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1">0.068</td></tr><tr><td rowspan="1" colspan="1"><italic>SY</italic></td><td align="char" char="." rowspan="1" colspan="1">35</td><td align="char" char="." rowspan="1" colspan="1">42</td><td align="char" char="." rowspan="1" colspan="1">0.56</td><td align="char" char="," rowspan="1" colspan="1">0.31, 1.01</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>YY</italic></td><td align="char" char="." rowspan="1" colspan="1">2</td><td align="char" char="." rowspan="1" colspan="1">4</td><td align="char" char="." rowspan="1" colspan="1">0.34</td><td align="char" char="," rowspan="1" colspan="1">0.03, 2.45</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="3" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Maraganore et al., 2004<xref ref-type="table-fn" rid="tblfn10">e</xref> (<xref ref-type="bibr" rid="bib91">91</xref>)</td><td rowspan="1" colspan="1"><italic>SS</italic></td><td align="char" char="." rowspan="1" colspan="1">120</td><td align="char" char="." rowspan="1" colspan="1">48</td><td align="char" char="." rowspan="1" colspan="1">1.00</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>SY</italic></td><td align="char" char="." rowspan="1" colspan="1">48</td><td align="char" char="." rowspan="1" colspan="1">25</td><td align="char" char="." rowspan="1" colspan="1">0.77</td><td align="char" char="," rowspan="1" colspan="1">0.41, 1.45</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>YY</italic></td><td align="char" char="." rowspan="1" colspan="1">7</td><td align="char" char="." rowspan="1" colspan="1">7</td><td align="char" char="." rowspan="1" colspan="1">0.4</td><td align="char" char="," rowspan="1" colspan="1">0.11, 1.42</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="3" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Zhang et al., 2000 (<xref ref-type="bibr" rid="bib108">108</xref>)</td><td rowspan="1" colspan="1"><italic>SS</italic></td><td align="char" char="." rowspan="1" colspan="1">108</td><td align="char" char="." rowspan="1" colspan="1">105</td><td align="char" char="." rowspan="1" colspan="1">1.00</td><td rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1">0.285</td></tr><tr><td rowspan="1" colspan="1"><italic>SY</italic></td><td align="char" char="." rowspan="1" colspan="1">40</td><td align="char" char="." rowspan="1" colspan="1">36</td><td align="char" char="." rowspan="1" colspan="1">1.08</td><td align="char" char="," rowspan="1" colspan="1">0.62, 1.89</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>YY</italic></td><td align="char" char="." rowspan="1" colspan="1">5</td><td align="char" char="." rowspan="1" colspan="1">1</td><td align="char" char="." rowspan="1" colspan="1">4.86</td><td align="char" char="," rowspan="1" colspan="1">0.53, 232.03</td><td rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn><p>Abbreviation: <italic>UCHL1</italic>, ubiquitin carboxyl-terminal esterase L1 gene.</p></fn><fn id="tblfn6"><label>a</label><p>Unadjusted odds ratios were calculated by the authors of the present review using raw genotype data presented in published studies.</p></fn><fn id="tblfn7"><label>b</label><p>Excluding cases included in genotype counts in the Momose et al. study (<xref ref-type="bibr" rid="bib107">107</xref>).</p></fn><fn id="tblfn8"><label>c</label><p>Incorrect count presented in the initial publication; corrected genotype count obtained from Maraganore et al. (<xref ref-type="bibr" rid="bib91">91</xref>).</p></fn><fn id="tblfn9"><label>d</label><p>Incorrect counts presented in the initial publication; corrected genotype counts obtained courtesy of the author.</p></fn><fn id="tblfn10"><label>e</label><p>Excluding cases included in genotype counts in the Maraganore et al. study (<xref ref-type="bibr" rid="bib20">20</xref>).</p></fn></table-wrap-foot></table-wrap><p><xref ref-type="fig" rid="fig1">Figure 1</xref> shows the results of the meta-analysis for populations reported to be of Asian ancestry. The overall odds ratio under a dominant model was not significantly different from 1 (odds ratio (OR) = 0.88, 95% confidence interval (CI): 0.68, 1.14; <italic>P</italic> = 0.33); however, there was evidence for a significant association under a recessive model (OR = 0.79, 95% CI: 0.67, 0.94; <italic>P</italic> = 0.01). Including the one study in which allele frequencies were not in Hardy-Weinberg equilibrium (<xref ref-type="bibr" rid="bib23">23</xref>) did not substantively change the results. There was marginal evidence for between-study heterogeneity under the dominant model (<italic>P</italic> = 0.044; <italic>I</italic><sup>2</sup> = 56.0%) but not under the recessive model (<italic>P</italic> = 0.463; <italic>I</italic><sup>2</sup> = 0.0%). The odds ratio for meta-analysis under a random-effects, additive model (coding genotypes 0, 1, 2 based on numbers of copies of the <italic>Y</italic> allele) was significant for populations of Asian descent (OR = 0.83, 95% CI: 0.71, 0.99; <italic>P</italic> = 0.029; <italic>I</italic><sup>2</sup> = 59.9%; heterogeneity <italic>P</italic> = 0.029). When we excluded the study out of Hardy-Weinberg equilibrium (Satoh and Kuroda (<xref ref-type="bibr" rid="bib23">23</xref>)), the odds ratio for meta-analysis under a random-effects, additive model suggested a trend toward reduced risk for populations of Asian descent, although it was not statistically significant (OR = 0.87, 95% CI: 0.75, 1.02; <italic>P</italic> = 0.080; <italic>I</italic><sup>2</sup>= 50.2%; heterogeneity <italic>P</italic> = 0.090).</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><p>Meta-analysis of published Parkinson's disease&#x02013;<italic>UCHL1</italic> S18Y case-control association studies of individuals of Asian ancestry: A) dominant and B) recessive model of inheritance. For each study (ordered by publication year), the odds ratio (OR) and 95% confidence interval (CI) for Parkinson's disease comparing the referent group to the risk group are shown. The overall odds ratio (dotted line and diamond) and 95% confidence interval (calculated under a random-effects model) are also shown. The referent group under the dominant model comprises the <italic>SS</italic> homozygotes, and the referent group under the recessive model comprises the <italic>SS</italic> homozygotes and <italic>SY</italic> heterozygotes. The size of each box, representing each odds ratio estimate, reflects the sample size of the study relative to the other studies. <italic>UCHL1</italic>, ubiquitin carboxyl-terminal esterase L1 gene.</p></caption><graphic xlink:href="amjepidkwp288f01_lw"/></fig><p><xref ref-type="fig" rid="fig2">Figure 2</xref> shows the results of the meta-analysis for subjects of European ancestry. In contrast to the results in Asian samples, the overall odds ratio under a dominant model was significantly different from 1 (OR = 0.89, 95% CI: 0.81, 0.98; <italic>P</italic> = 0.02); however, the odds ratio was not significant under a recessive model (OR = 0.92, 95% CI: 0.66, 1.30; <italic>P</italic> = 0.65). Excluding data from the first study published (<xref ref-type="bibr" rid="bib20">20</xref>) or from the family-based study (<xref ref-type="bibr" rid="bib92">92</xref>) did not substantively change the results of the analysis. There was no significant evidence for heterogeneity between studies (<italic>P</italic> = 0.355, <italic>I</italic><sup>2</sup> = 11.0% for the dominant model; <italic>P</italic> = 0.154, <italic>I</italic><sup>2</sup> = 25.1% for the recessive model). The odds ratio for meta-analysis under a random-effects, additive model (coding genotypes 0, 1, 2 based on numbers of copies of the <italic>Y</italic> allele) was significant in populations of European descent (OR = 0.90, 95% CI: 0.82, 0.99; <italic>P</italic> = 0.035; <italic>I</italic><sup>2</sup>= 21.9%; heterogeneity <italic>P</italic> = 0.23).</p><fig id="fig2" position="float"><label>Figure 2.</label><caption><p>Meta-analysis of published Parkinson's disease&#x02013;<italic>UCHL1</italic> S18Y case-control association studies of individuals of European ancestry: A) dominant and B) recessive model of inheritance. For each study (ordered by publication year), the odds ratio (OR) and 95% confidence interval (CI) for Parkinson's disease comparing the referent group to the risk group are shown. The overall odds ratio (dotted line and diamond) and 95% confidence interval (calculated under a random-effects model) are also shown. The referent group under the dominant model comprises the <italic>SS</italic> homozygotes, and the referent group under the recessive model comprises the <italic>SS</italic> homozygotes and <italic>SY</italic> heterozygotes. The size of each box, representing each odds ratio estimate, reflects the sample size of the study relative to the other studies. Complete data from Maraganore et al. (<xref ref-type="bibr" rid="bib91">91</xref>) are presented (including data from Maraganore et al. (<xref ref-type="bibr" rid="bib20">20</xref>) and additional data included in Maraganore et al. (<xref ref-type="bibr" rid="bib91">91</xref>)). <italic>UCHL1</italic>, ubiquitin carboxyl-terminal esterase L1 gene.</p></caption><graphic xlink:href="amjepidkwp288f02_lw"/></fig><p>Two studies previously performed analyses to summarize the association between the <italic>UCHL1</italic> S18Y variant and Parkinson's disease across studies. The first was a pooled analysis by Maraganore et al. (<xref ref-type="bibr" rid="bib91">91</xref>), combining data from 11 studies with subjects of both European and Asian descent, including an unpublished abstract not used in our review (<xref ref-type="bibr" rid="bib96">96</xref>). The authors of this pooled analysis concluded that <italic>UCHL1</italic> is a susceptibility gene, with carriers of the <italic>Y</italic> allele at reduced risk of Parkinson's disease (meta-analysis OR under a dominant model comparing <italic>Y/Y</italic> + <italic>Y/S</italic> vs. <italic>S/S</italic> = 0.84, 95% CI: 0.73, 0.95). The second was a meta-analysis by Healy et al. (<xref ref-type="bibr" rid="bib26">26</xref>) that examined 8 studies of white subjects and concluded that <italic>UCHL1</italic> is not a susceptibility gene (meta-analysis under a dominant model OR = 0.96, 95% CI: 0.86, 1.08).</p><p>The major difference between the 2 meta-analyses was the ethnic groups studied. Maraganore et al. (<xref ref-type="bibr" rid="bib91">91</xref>) included all studies, whereas Healy et al. (<xref ref-type="bibr" rid="bib26">26</xref>) restricted their meta-analysis to white populations. Indeed, in the Maraganore et al. study, the meta-analysis results were not significant when restricted to white populations. Our results are consistent with these findings, in that we found slight differences in the meta-analysis results for populations of Asian descent compared with populations of European descent. Notably, the association was significant under a recessive model in Asian populations but under a dominant model in populations of European descent. This finding may reflect underlying biologic differences or simply the differences in allele frequencies. There is more power to detect a recessive association in populations of Asian descent, because the minor allele frequency is higher.</p></sec><sec><title>INTERACTIONS</title><p>Most association studies of the <italic>UCHL1</italic> S18Y variant and Parkinson's disease have focused on main effects between S18Y and case-control status. However, a number of studies have also examined potential effect modification by age. More specifically, 4 studies found evidence for an association when restricting the analysis to early-onset cases (<xref ref-type="bibr" rid="bib20">20</xref>, <xref ref-type="bibr" rid="bib97">97</xref>&#x02013;<xref ref-type="bibr" rid="bib99">99</xref>), but 3 studies did not (<xref ref-type="bibr" rid="bib1">1</xref>, <xref ref-type="bibr" rid="bib95">95</xref>, <xref ref-type="bibr" rid="bib100">100</xref>). A major difficulty when comparing results across studies is the difference in the age cutoff used to define early onset. The most common was 50 years (<xref ref-type="bibr" rid="bib1">1</xref>, <xref ref-type="bibr" rid="bib95">95</xref>, <xref ref-type="bibr" rid="bib98">98</xref>&#x02013;<xref ref-type="bibr" rid="bib101">101</xref>), but cutoff points of 59 years (<xref ref-type="bibr" rid="bib102">102</xref>) and 67 years (<xref ref-type="bibr" rid="bib91">91</xref>) were also used. Further studies differ as to whether cases were stratified by age at onset, age at diagnosis, or age at study entry and whether controls were also stratified by age. These inconsistencies limit our ability to perform a rigorous meta-analysis stratified by age.</p><p>To date, 3 studies have examined gene-gene and/or gene-environment interactions involving <italic>UCHL1</italic> and Parkinson's disease. Elbaz et al. (<xref ref-type="bibr" rid="bib97">97</xref>) examined potential interactions of the <italic>UCHL1</italic> S18Y variant with smoking and pesticide use; they did not observe a main effect for the S18Y variant, and there was no evidence for an interaction with either of these environmental exposures. Maraganore et al. (<xref ref-type="bibr" rid="bib103">103</xref>) reported evidence for gene-gene interaction between <italic>UCHL1</italic> and &#x003b1;-synuclein genotypes in women, although they did not find an interaction in men. A third study by McCulloch et al. (<xref ref-type="bibr" rid="bib84">84</xref>) examined <italic>UCHL1</italic> S18Y in conjunction with 3 other candidate gene polymorphisms (<italic>SNCA</italic> Rep1, <italic>MAPT</italic> H1/H2 haplotypes, and apolipoprotein E (<italic>APOE</italic>) e2/e3/e4) and 2 environmental factors (smoking and caffeinated coffee consumption). The authors did not observe evidence for a main effect with <italic>UCHL1</italic> S18Y or for interactions with smoking or caffeinated coffee consumption. However, they did report evidence for gene-environment interactions for polymorphisms in <italic>APOE</italic> and coffee as well as for <italic>SNCA</italic> and smoking (<xref ref-type="bibr" rid="bib84">84</xref>).</p></sec><sec><title>LABORATORY AND POPULATION TESTS</title><p><italic>UCHL1</italic> genotyping is performed routinely in research settings; however, a <italic>UCHL1</italic> laboratory test is not commercially available at this time. Given the lack of conclusive evidence supporting a strong association between <italic>UCHL1</italic> polymorphisms and Parkinson's disease, it seems unlikely that <italic>UCHL1</italic> population testing will be undertaken in the near future.</p></sec><sec><title>OTHER PUBLIC HEALTH APPLICATIONS</title><p>The Venice criteria were developed by the Human Genome Epidemiology Network (HuGENet) Working Group to provide guidance in assessing the cumulative epidemiologic evidence of genetic association studies (<xref ref-type="bibr" rid="bib104">104</xref>). Briefly, Ioannidis et al. (<xref ref-type="bibr" rid="bib104">104</xref>) suggest that 3 areas be considered when assessing the published literature: amount of evidence, replication, and protection from bias. The evidence in each of these areas is scored as either A, B, or C and is used in combination to provide an overall assessment of the credibility of the association between the genetic variant and phenotype in question. Evidence meeting the highest standards are given a score of A (more than 1,000 total subjects in the least common genotype group; extensive replication with good consistency between studies; little to no obvious bias in estimates for amount of evidence, replication, and protection from bias), whereas meeting moderate criteria receives a score of B (e.g., 100&#x02013;1,000 total subjects in the least common genotype group; replication, but moderate inconsistency between studies; missing information to assess bias), and those of lowest quality receive a score of C. These criteria were applied as follows to evaluate the overall evidence for an association between the <italic>UCHL1</italic> S18Y variant and Parkinson's disease.</p><p>First, we considered the amount of evidence. In Asian samples, our meta-analysis showed a significantly reduced risk of Parkinson's disease for the <italic>Y</italic> variant under a recessive model but not under a dominant model. In populations of European descent, our meta-analysis found a significantly reduced risk of Parkinson's disease under a dominant model but not a recessive model. The frequency of the <italic>Y</italic> allele ranges from 47% to 61% in samples from Asian countries and from 16% to 22% in populations of European origin, and the total sample size in our meta-analysis was 13,398 cases and controls (3,412 Asian, 9,986 European). Therefore, the amount of evidence supporting the association exceeds the <italic>n</italic> (minor allele) = 1,000 needed to qualify as &#x0201c;large-scale evidence&#x0201d; (category A). Second, we considered the level of replication. We observed only minimal between-study heterogeneity in our meta-analysis; however, the total number of studies examining the association of <italic>UCHL1</italic> S18Y with Parkinson's disease in each ethnic group was relatively small. Therefore, we consider the credibility based on replication to be part of category B.</p><p>Finally, we considered the potential for bias. There was no obvious bias that may have affected the <italic>UCHL1</italic>&#x02013;Parkinson's disease association, but, as is true for many candidate gene studies, most studies did not publish sufficient information to fully evaluate the potential for bias (<xref ref-type="bibr" rid="bib16">16</xref>). Bias is a particularly important issue regarding the association between <italic>UCHL1</italic> S18Y and Parkinson's disease given the relatively small magnitude of the effect. A weak amount of bias could drive the entire association. Thus, we assign a score of B for protection from bias. The overall score using the Venice criteria is therefore &#x0201c;ABB,&#x0201d; consistent with moderate evidence supporting the association between <italic>UCHL1</italic> S18Y and Parkinson's disease.</p><p>Given the moderate degree of evidence for <italic>UCHL1</italic> as a Parkinson's disease susceptibility gene, and the lack of effective prevention measures for Parkinson's disease, there is no current public health application for this association. This situation might change in the future if neuroprotective therapies are developed that, if started earlier, could delay disease onset. Finally, it is also possible that interactions between genetic variants and pharmacologic agents will be identified such that genotypes for <italic>UCHL1</italic> or other susceptibility genes might prove useful in tailoring a patient's medication regimen.</p></sec><sec><title>CONCLUSIONS AND RECOMMENDATIONS FOR FUTURE RESEARCH</title><p>In summary, the evidence for the S18Y variant of <italic>UCHL1</italic> as a Parkinson's disease susceptibility factor is moderate and suggests an effect size of 0.79&#x02013;0.92. This effect size is similar to the magnitude of effect sizes reported by other genome-wide association studies of complex disease (<xref ref-type="bibr" rid="bib76">76</xref>) and for replication of candidate genes (<xref ref-type="bibr" rid="bib103">103</xref>). Two previous meta-analyses have been published on this subject. We added 2 studies in Asian populations and 2 studies in populations of European descent not included in the previous meta-analyses. Consistent with Maraganore et al. (<xref ref-type="bibr" rid="bib91">91</xref>), we found a significant result under a recessive model but not a dominant model in Asian populations. Our paper is the first known to show a significant association in a meta-analysis of populations of European descent, although both previous meta-analyses found a nonsignificant trend toward an association in a dominant model (<xref ref-type="bibr" rid="bib26">26</xref>, <xref ref-type="bibr" rid="bib91">91</xref>). It is possible that our study is the first adequately powered to detect a significant association given the moderate effect size and the lower allele frequency in European populations.</p><p>Additional large, well-designed studies in Asian populations and in other ethnic groups are needed to determine whether these effects are consistent across groups. Ideally, these studies would have adequate sample sizes and detailed/standardized phenotypic information to comprehensively evaluate gene-gene and gene-environment interactions. Such studies would benefit from using a tagSNP approach to comprehensively examine variation across the <italic>UCHL1</italic> gene rather than focusing solely on the S18Y variant.</p><p>Additional research focusing on the molecular biology of <italic>UCHL1</italic> function and Parkinson's disease is also needed. In particular, studies should attempt to better elucidate the role of <italic>UCHL1</italic> in neuronal function and the role of the ubiquitin proteasome system in Parkinson's disease pathogenesis (<xref ref-type="bibr" rid="bib105">105</xref>). Combining human genetic studies and functional analyses may provide new insights that could ultimately translate into more effective prevention and treatment options for Parkinson's disease.</p></sec></body><back><glossary><def-list><title>Abbreviations</title><def-item><term>CI</term><def><p>confidence interval</p></def></def-item><def-item><term>OR</term><def><p>odds ratio</p></def></def-item><def-item><term>PARK</term><def><p>a region identified in linkage studies of Parkinson's disease</p></def></def-item><def-item><term>SNP</term><def><p>single nucleotide polymorphism</p></def></def-item><def-item><term>UCHL1</term><def><p>ubiquitin carboxyl-terminal esterase L1</p></def></def-item></def-list></glossary><ack><p>Author affiliations: Department of Epidemiology, University of Washington School of Public Health, Seattle, Washington (Margaret Ragland, Carolyn Hutter, Karen Edwards); Institute for Public Health Genetics, University of Washington School of Public Health, Seattle, Washington (Margaret Ragland, Karen Edwards); Geriatric Research Education and Clinical Center, Veterans Affairs Puget Sound Health Care System, Seattle, Washington (Cyrus Zabetian); and Department of Neurology, University of Washington School of Medicine, Seattle, Washington (Cyrus Zabetian).</p><p>This project was financially supported under a cooperative agreement from the Centers for Disease Control and Prevention through the Association of Schools of Public Health, grant U36/CCU300430-23 and U10/CCU025038 (Karen L. Edwards, Principal Investigator).</p><p>The authors thank Saee Hamine for her assistance in preparing the manuscript for publication.</p><p>Conflict of interest: none declared.</p></ack><ref-list><ref id="bib1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Healy</surname><given-names>DG</given-names></name><name><surname>Abou-Sleiman</surname><given-names>PM</given-names></name><name><surname>Wood</surname><given-names>NW</given-names></name></person-group><article-title>Genetic causes of Parkinson's disease: <italic>UCHL-1</italic></article-title><source>Cell Tissue Res.</source><year>2004</year><volume>318</volume><issue>1</issue><fpage>189</fpage><lpage>194</lpage><pub-id pub-id-type="pmid">15221445</pub-id></element-citation></ref><ref id="bib2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>J</given-names></name><name><surname>Tao</surname><given-names>Q</given-names></name><name><surname>Cheung</surname><given-names>KF</given-names></name><etal/></person-group><article-title>Epigenetic identification of ubiquitin carboxyl-terminal hydrolase L1 as a functional tumor suppressor and biomarker for hepatocellular carcinoma and other digestive tumors</article-title><source>Hepatology</source><year>2008</year><volume>48</volume><issue>2</issue><fpage>508</fpage><lpage>518</lpage><pub-id pub-id-type="pmid">18666234</pub-id></element-citation></ref><ref id="bib3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilkinson</surname><given-names>KD</given-names></name><name><surname>Lee</surname><given-names>KM</given-names></name><name><surname>Deshpande</surname><given-names>S</given-names></name><etal/></person-group><article-title>The neuron-specific protein PGP 9.5 is a ubiquitin carboxyl-terminal hydrolase</article-title><source>Science</source><year>1989</year><volume>246</volume><issue>4930</issue><fpage>670</fpage><lpage>673</lpage><pub-id pub-id-type="pmid">2530630</pub-id></element-citation></ref><ref id="bib4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lowe</surname><given-names>J</given-names></name><name><surname>McDermott</surname><given-names>H</given-names></name><name><surname>Landon</surname><given-names>M</given-names></name><etal/></person-group><article-title>Ubiquitin carboxyl-terminal hydrolase (PGP 9.5) is selectively present in ubiquitinated inclusion bodies characteristic of human neurodegenerative diseases</article-title><source>J Pathol</source><year>1990</year><volume>161</volume><issue>2</issue><fpage>153</fpage><lpage>160</lpage><pub-id pub-id-type="pmid">2166150</pub-id></element-citation></ref><ref id="bib5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moore</surname><given-names>DJ</given-names></name><name><surname>West</surname><given-names>AB</given-names></name><name><surname>Dawson</surname><given-names>VL</given-names></name><etal/></person-group><article-title>Molecular pathophysiology of Parkinson's disease</article-title><source>Annu Rev Neurosci</source><year>2005</year><volume>28</volume><fpage>57</fpage><lpage>87</lpage><pub-id pub-id-type="pmid">16022590</pub-id></element-citation></ref><ref id="bib6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ciechanover</surname><given-names>A</given-names></name><name><surname>Brundin</surname><given-names>P</given-names></name></person-group><article-title>The ubiquitin proteasome system in neurodegenerative diseases: sometimes the chicken, sometimes the egg</article-title><source>Neuron</source><year>2003</year><volume>40</volume><issue>2</issue><fpage>427</fpage><lpage>446</lpage><pub-id pub-id-type="pmid">14556719</pub-id></element-citation></ref><ref id="bib7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname><given-names>KL</given-names></name><name><surname>Tan</surname><given-names>JM</given-names></name></person-group><article-title>Role of the ubiquitin proteasome system in Parkinson's disease</article-title><source>BMC Biochem</source><year>2007</year><volume>8</volume><issue>suppl 1</issue><fpage>S13</fpage><pub-id pub-id-type="pmid">18047737</pub-id></element-citation></ref><ref id="bib8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wing</surname><given-names>SS</given-names></name></person-group><article-title>Deubiquitinating enzymes&#x02014;the importance of driving in reverse along the ubiquitin-proteasome pathway</article-title><source>Int J Biochem Cell Biol.</source><year>2003</year><volume>35</volume><issue>5</issue><fpage>590</fpage><lpage>605</lpage><pub-id pub-id-type="pmid">12672452</pub-id></element-citation></ref><ref id="bib9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Fallon</surname><given-names>L</given-names></name><name><surname>Lashuel</surname><given-names>HA</given-names></name><etal/></person-group><article-title>The <italic>UCH-L1</italic> gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson's disease susceptibility</article-title><source>Cell.</source><year>2002</year><volume>111</volume><issue>2</issue><fpage>209</fpage><lpage>218</lpage><pub-id pub-id-type="pmid">12408865</pub-id></element-citation></ref><ref id="bib10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saigoh</surname><given-names>K</given-names></name><name><surname>Wang</surname><given-names>YL</given-names></name><name><surname>Suh</surname><given-names>JG</given-names></name><etal/></person-group><article-title>Intragenic deletion in the gene encoding ubiquitin carboxy-terminal hydrolase in gad mice</article-title><source>Nat Genet.</source><year>1999</year><volume>23</volume><issue>1</issue><fpage>47</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">10471497</pub-id></element-citation></ref><ref id="bib11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Osaka</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>YL</given-names></name><name><surname>Takada</surname><given-names>K</given-names></name><etal/></person-group><article-title>Ubiquitin carboxy-terminal hydrolase L1 binds to and stabilizes monoubiquitin in neuron</article-title><source>Hum Mol Genet.</source><year>2003</year><volume>12</volume><issue>16</issue><fpage>1945</fpage><lpage>1958</lpage><pub-id pub-id-type="pmid">12913066</pub-id></element-citation></ref><ref id="bib12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meray</surname><given-names>RK</given-names></name><name><surname>Lansbury</surname><given-names>PT</given-names><suffix>Jr</suffix></name></person-group><article-title>Reversible monoubiquitination regulates the Parkinson disease-associated ubiquitin hydrolase UCH-L1</article-title><source>J Biol Chem.</source><year>2007</year><volume>282</volume><issue>14</issue><fpage>10567</fpage><lpage>10575</lpage><pub-id pub-id-type="pmid">17259170</pub-id></element-citation></ref><ref id="bib13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naz&#x000e9;</surname><given-names>P</given-names></name><name><surname>Vuillaume</surname><given-names>I</given-names></name><name><surname>Dest&#x000e9;e</surname><given-names>A</given-names></name><etal/></person-group><article-title>Mutation analysis and association studies of the ubiquitin carboxy-terminal hydrolase L1 gene in Huntington's disease</article-title><source>Neurosci Lett.</source><year>2002</year><volume>328</volume><issue>1</issue><fpage>1</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">12123845</pub-id></element-citation></ref><ref id="bib14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ross</surname><given-names>CA</given-names></name><name><surname>Pickart</surname><given-names>CM</given-names></name></person-group><article-title>The ubiquitin-proteasome pathway in Parkinson's disease and other neurodegenerative diseases</article-title><source>Trends Cell Biol.</source><year>2004</year><volume>14</volume><issue>12</issue><fpage>703</fpage><lpage>711</lpage><pub-id pub-id-type="pmid">15564047</pub-id></element-citation></ref><ref id="bib15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xue</surname><given-names>S</given-names></name><name><surname>Jia</surname><given-names>J</given-names></name></person-group><article-title>Genetic association between ubiquitin carboxy-terminal hydrolase-L1 gene S18Y polymorphism and sporadic Alzheimer's disease in a Chinese Han population</article-title><source>Brain Res.</source><year>2006</year><volume>1087</volume><issue>1</issue><fpage>28</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">16626667</pub-id></element-citation></ref><ref id="bib16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kagara</surname><given-names>I</given-names></name><name><surname>Enokida</surname><given-names>H</given-names></name><name><surname>Kawakami</surname><given-names>K</given-names></name><etal/></person-group><article-title>CpG hypermethylation of the <italic>UCHL1</italic> gene promoter is associated with pathogenesis and poor prognosis in renal cell carcinoma</article-title><source>J Urol</source><year>2008</year><volume>180</volume><issue>1</issue><fpage>343</fpage><lpage>351</lpage><pub-id pub-id-type="pmid">18499164</pub-id></element-citation></ref><ref id="bib17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okochi-Takada</surname><given-names>E</given-names></name><name><surname>Nakazawa</surname><given-names>K</given-names></name><name><surname>Wakabayashi</surname><given-names>M</given-names></name><etal/></person-group><article-title>Silencing of the <italic>UCHL1</italic> gene in human colorectal and ovarian cancers</article-title><source>Int J Cancer</source><year>2006</year><volume>119</volume><issue>6</issue><fpage>1338</fpage><lpage>1344</lpage><pub-id pub-id-type="pmid">16642472</pub-id></element-citation></ref><ref id="bib18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leroy</surname><given-names>E</given-names></name><name><surname>Boyer</surname><given-names>R</given-names></name><name><surname>Auburger</surname><given-names>G</given-names></name><etal/></person-group><article-title>The ubiquitin pathway in Parkinson's disease</article-title><source>Nature</source><year>1998</year><volume>395</volume><issue>6701</issue><fpage>451</fpage><lpage>452</lpage><pub-id pub-id-type="pmid">9774100</pub-id></element-citation></ref><ref id="bib19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nishikawa</surname><given-names>K</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Kawamura</surname><given-names>R</given-names></name><etal/></person-group><article-title>Alterations of structure and hydrolase activity of parkinsonism-associated human ubiquitin carboxyl-terminal hydrolase L1 variants</article-title><source>Biochem Biophys Res Commun</source><year>2003</year><volume>304</volume><issue>1</issue><fpage>176</fpage><lpage>183</lpage><pub-id pub-id-type="pmid">12705903</pub-id></element-citation></ref><ref id="bib20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maraganore</surname><given-names>DM</given-names></name><name><surname>Farrer</surname><given-names>MJ</given-names></name><name><surname>Hardy</surname><given-names>JA</given-names></name><etal/></person-group><article-title>Case-control study of the ubiquitin carboxy-terminal hydrolase L1 gene in Parkinson's disease</article-title><source>Neurology</source><year>1999</year><volume>53</volume><issue>8</issue><fpage>1858</fpage><lpage>1860</lpage><pub-id pub-id-type="pmid">10563640</pub-id></element-citation></ref><ref id="bib21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harhangi</surname><given-names>BS</given-names></name><name><surname>Farrer</surname><given-names>MJ</given-names></name><name><surname>Lincoln</surname><given-names>S</given-names></name><etal/></person-group><article-title>The Ile93Met mutation in the ubiquitin carboxy-terminal-hydrolase-L1 gene is not observed in European cases with familial Parkinson's disease</article-title><source>Neurosci Lett.</source><year>1999</year><volume>270</volume><issue>1</issue><fpage>1</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">10454131</pub-id></element-citation></ref><ref id="bib22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lincoln</surname><given-names>S</given-names></name><name><surname>Vaughan</surname><given-names>J</given-names></name><name><surname>Wood</surname><given-names>N</given-names></name><etal/></person-group><article-title>Low frequency of pathogenic mutations in the ubiquitin carboxy-terminal hydrolase gene in familial Parkinson's disease</article-title><source>Neuroreport</source><year>1999</year><volume>10</volume><issue>2</issue><fpage>427</fpage><lpage>429</lpage><pub-id pub-id-type="pmid">10203348</pub-id></element-citation></ref><ref id="bib23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Satoh</surname><given-names>J</given-names></name><name><surname>Kuroda</surname><given-names>Y</given-names></name></person-group><article-title>A polymorphic variation of serine to tyrosine at codon 18 in the ubiquitin C-terminal hydrolase-L1 gene is associated with a reduced risk of sporadic Parkinson's disease in a Japanese population</article-title><source>J Neurol Sci.</source><year>2001</year><volume>189</volume><issue>1-2</issue><fpage>113</fpage><lpage>117</lpage><pub-id pub-id-type="pmid">11535241</pub-id></element-citation></ref><ref id="bib24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>Q</given-names></name><name><surname>Tao</surname><given-names>E</given-names></name></person-group><article-title>An Ile93Met substitution in the <italic>UCH-L1</italic> gene is not a disease-causing mutation for idiopathic Parkinson's disease</article-title><source>Chin Med J (Engl)</source><year>2003</year><volume>116</volume><issue>2</issue><fpage>312</fpage><lpage>313</lpage><pub-id pub-id-type="pmid">12775255</pub-id></element-citation></ref><ref id="bib25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wintermeyer</surname><given-names>P</given-names></name><name><surname>Kr&#x000fc;ger</surname><given-names>R</given-names></name><name><surname>Kuhn</surname><given-names>W</given-names></name><etal/></person-group><article-title>Mutation analysis and association studies of the <italic>UCHL1</italic> gene in German Parkinson's disease patients</article-title><source>Neuroreport</source><year>2000</year><volume>11</volume><issue>10</issue><fpage>2079</fpage><lpage>2082</lpage><pub-id pub-id-type="pmid">10923647</pub-id></element-citation></ref><ref id="bib26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Healy</surname><given-names>DG</given-names></name><name><surname>Abou-Sleiman</surname><given-names>PM</given-names></name><name><surname>Casas</surname><given-names>JP</given-names></name><etal/></person-group><article-title><italic>UCHL-1</italic> is not a Parkinson's disease susceptibility gene</article-title><source>Ann Neurol</source><year>2006</year><volume>59</volume><issue>4</issue><fpage>627</fpage><lpage>633</lpage><pub-id pub-id-type="pmid">16450370</pub-id></element-citation></ref><ref id="bib27"><label>27.</label><element-citation publication-type="journal"><collab>International HapMap Consortium</collab><article-title>The International HapMap Project</article-title><source>Nature</source><year>2003</year><volume>426</volume><issue>6968</issue><fpage>789</fpage><lpage>796</lpage><pub-id pub-id-type="pmid">14685227</pub-id></element-citation></ref><ref id="bib28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carlson</surname><given-names>CS</given-names></name><name><surname>Eberle</surname><given-names>MA</given-names></name><name><surname>Rieder</surname><given-names>MJ</given-names></name><etal/></person-group><article-title>Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium</article-title><source>Am J Hum Genet.</source><year>2004</year><volume>74</volume><issue>1</issue><fpage>106</fpage><lpage>120</lpage><pub-id pub-id-type="pmid">14681826</pub-id></element-citation></ref><ref id="bib29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Samii</surname><given-names>A</given-names></name><name><surname>Nutt</surname><given-names>JG</given-names></name><name><surname>Ransom</surname><given-names>BR</given-names></name></person-group><article-title>Parkinson's disease</article-title><source>Lancet</source><year>2004</year><volume>363</volume><issue>9423</issue><fpage>1783</fpage><lpage>1793</lpage><pub-id pub-id-type="pmid">15172778</pub-id></element-citation></ref><ref id="bib30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jankovic</surname><given-names>J</given-names></name></person-group><article-title>Parkinson's disease: clinical features and diagnosis</article-title><source>J Neurol Neurosurg Psychiatry</source><year>2008</year><volume>79</volume><issue>4</issue><fpage>368</fpage><lpage>376</lpage><pub-id pub-id-type="pmid">18344392</pub-id></element-citation></ref><ref id="bib31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forno</surname><given-names>LS</given-names></name></person-group><article-title>Neuropathology of Parkinson's disease</article-title><source>J Neuropathol Exp Neurol</source><year>1996</year><volume>55</volume><issue>3</issue><fpage>259</fpage><lpage>272</lpage><pub-id pub-id-type="pmid">8786384</pub-id></element-citation></ref><ref id="bib32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leverenz</surname><given-names>JB</given-names></name><name><surname>Umar</surname><given-names>I</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><etal/></person-group><article-title>Proteomic identification of novel proteins in cortical Lewy bodies</article-title><source>Brain Pathol</source><year>2007</year><volume>17</volume><issue>2</issue><fpage>139</fpage><lpage>145</lpage><pub-id pub-id-type="pmid">17388944</pub-id></element-citation></ref><ref id="bib33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spillantini</surname><given-names>MG</given-names></name><name><surname>Crowther</surname><given-names>RA</given-names></name><name><surname>Jakes</surname><given-names>R</given-names></name><etal/></person-group><article-title>Alpha-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies</article-title><source>Proc Natl Acad Sci U S A</source><year>1998</year><volume>95</volume><issue>11</issue><fpage>6469</fpage><lpage>6473</lpage><pub-id pub-id-type="pmid">9600990</pub-id></element-citation></ref><ref id="bib34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fearnley</surname><given-names>JM</given-names></name><name><surname>Lees</surname><given-names>AJ</given-names></name></person-group><article-title>Ageing and Parkinson's disease: substantia nigra regional selectivity</article-title><source>Brain</source><year>1991</year><volume>114</volume><issue>pt 5</issue><fpage>2283</fpage><lpage>2301</lpage><pub-id pub-id-type="pmid">1933245</pub-id></element-citation></ref><ref id="bib35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hughes</surname><given-names>AJ</given-names></name><name><surname>Ben-Shlomo</surname><given-names>Y</given-names></name><name><surname>Daniel</surname><given-names>SE</given-names></name><etal/></person-group><article-title>What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study</article-title><source>Neurology</source><year>1992</year><volume>42</volume><issue>6</issue><fpage>1142</fpage><lpage>1146</lpage><pub-id pub-id-type="pmid">1603339</pub-id></element-citation></ref><ref id="bib36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hughes</surname><given-names>AJ</given-names></name><name><surname>Daniel</surname><given-names>SE</given-names></name><name><surname>Ben-Shlomo</surname><given-names>Y</given-names></name><etal/></person-group><article-title>The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service</article-title><source>Brain</source><year>2002</year><volume>125</volume><issue>pt 4</issue><fpage>861</fpage><lpage>870</lpage><pub-id pub-id-type="pmid">11912118</pub-id></element-citation></ref><ref id="bib37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hughes</surname><given-names>AJ</given-names></name><name><surname>Daniel</surname><given-names>SE</given-names></name><name><surname>Kilford</surname><given-names>L</given-names></name><etal/></person-group><article-title>Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases</article-title><source>J Neurol Neurosurg Psychiatry</source><year>1992</year><volume>55</volume><issue>3</issue><fpage>181</fpage><lpage>184</lpage><pub-id pub-id-type="pmid">1564476</pub-id></element-citation></ref><ref id="bib38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hughes</surname><given-names>AJ</given-names></name><name><surname>Daniel</surname><given-names>SE</given-names></name><name><surname>Lees</surname><given-names>AJ</given-names></name></person-group><article-title>Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease</article-title><source>Neurology</source><year>2001</year><volume>57</volume><issue>8</issue><fpage>1497</fpage><lpage>1499</lpage><pub-id pub-id-type="pmid">11673599</pub-id></element-citation></ref><ref id="bib39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rajput</surname><given-names>AH</given-names></name><name><surname>Rozdilsky</surname><given-names>B</given-names></name><name><surname>Rajput</surname><given-names>A</given-names></name></person-group><article-title>Accuracy of clinical diagnosis in parkinsonism&#x02014;a prospective study</article-title><source>Can J Neurol Sci.</source><year>1991</year><volume>18</volume><issue>3</issue><fpage>275</fpage><lpage>278</lpage><pub-id pub-id-type="pmid">1913360</pub-id></element-citation></ref><ref id="bib40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gibb</surname><given-names>WR</given-names></name><name><surname>Lees</surname><given-names>AJ</given-names></name></person-group><article-title>The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease</article-title><source>J Neurol Neurosurg Psychiatry</source><year>1988</year><volume>51</volume><issue>6</issue><fpage>745</fpage><lpage>752</lpage><pub-id pub-id-type="pmid">2841426</pub-id></element-citation></ref><ref id="bib41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dorsey</surname><given-names>ER</given-names></name><name><surname>Constantinescu</surname><given-names>R</given-names></name><name><surname>Thompson</surname><given-names>JP</given-names></name><etal/></person-group><article-title>Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030</article-title><source>Neurology</source><year>2007</year><volume>68</volume><issue>5</issue><fpage>384</fpage><lpage>386</lpage><pub-id pub-id-type="pmid">17082464</pub-id></element-citation></ref><ref id="bib42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shulman</surname><given-names>LM</given-names></name><name><surname>Bhat</surname><given-names>V</given-names></name></person-group><article-title>Gender disparities in Parkinson's disease</article-title><source>Expert Rev Neurother</source><year>2006</year><volume>6</volume><issue>3</issue><fpage>407</fpage><lpage>416</lpage><pub-id pub-id-type="pmid">16533144</pub-id></element-citation></ref><ref id="bib43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elbaz</surname><given-names>A</given-names></name><name><surname>Bower</surname><given-names>JH</given-names></name><name><surname>Maraganore</surname><given-names>DM</given-names></name><etal/></person-group><article-title>Risk tables for parkinsonism and Parkinson's disease</article-title><source>J Clin Epidemiol</source><year>2002</year><volume>55</volume><issue>1</issue><fpage>25</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">11781119</pub-id></element-citation></ref><ref id="bib44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirtz</surname><given-names>D</given-names></name><name><surname>Thurman</surname><given-names>DJ</given-names></name><name><surname>Gwinn-Hardy</surname><given-names>K</given-names></name><etal/></person-group><article-title>How common are the &#x0201c;common&#x0201d; neurologic disorders?</article-title><source>Neurology</source><year>2007</year><volume>68</volume><issue>5</issue><fpage>326</fpage><lpage>337</lpage><pub-id pub-id-type="pmid">17261678</pub-id></element-citation></ref><ref id="bib45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elbaz</surname><given-names>A</given-names></name><name><surname>Tranchant</surname><given-names>C</given-names></name></person-group><article-title>Epidemiologic studies of environmental exposures in Parkinson's disease</article-title><source>J Neurol Sci.</source><year>2007</year><volume>262</volume><issue>1&#x02013;2</issue><fpage>37</fpage><lpage>44</lpage><pub-id pub-id-type="pmid">17673256</pub-id></element-citation></ref><ref id="bib46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>von Campenhausen</surname><given-names>S</given-names></name><name><surname>Bornschein</surname><given-names>B</given-names></name><name><surname>Wick</surname><given-names>R</given-names></name><etal/></person-group><article-title>Prevalence and incidence of Parkinson's disease in Europe</article-title><source>Eur Neuropsychopharmacol</source><year>2005</year><volume>15</volume><issue>4</issue><fpage>473</fpage><lpage>490</lpage><pub-id pub-id-type="pmid">15963700</pub-id></element-citation></ref><ref id="bib47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>ZX</given-names></name><name><surname>Roman</surname><given-names>GC</given-names></name><name><surname>Hong</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Parkinson's disease in China: prevalence in Beijing, Xian, and Shanghai</article-title><source>Lancet</source><year>2005</year><volume>365</volume><issue>9459</issue><fpage>595</fpage><lpage>597</lpage><pub-id pub-id-type="pmid">15708103</pub-id></element-citation></ref><ref id="bib48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okubadejo</surname><given-names>NU</given-names></name><name><surname>Bower</surname><given-names>JH</given-names></name><name><surname>Rocca</surname><given-names>WA</given-names></name><etal/></person-group><article-title>Parkinson's disease in Africa: a systematic review of epidemiologic and genetic studies</article-title><source>Mov Disord</source><year>2006</year><volume>21</volume><issue>12</issue><fpage>2150</fpage><lpage>2156</lpage><pub-id pub-id-type="pmid">17044056</pub-id></element-citation></ref><ref id="bib49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schoenberg</surname><given-names>BS</given-names></name><name><surname>Osuntokun</surname><given-names>BO</given-names></name><name><surname>Adeuja</surname><given-names>AO</given-names></name><etal/></person-group><article-title>Comparison of the prevalence of Parkinson's disease in black populations in the rural United States and in rural Nigeria: door-to-door community studies</article-title><source>Neurology</source><year>1988</year><volume>38</volume><issue>4</issue><fpage>645</fpage><lpage>646</lpage><pub-id pub-id-type="pmid">3352927</pub-id></element-citation></ref><ref id="bib50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Albert</surname><given-names>SM</given-names></name></person-group><article-title>Projecting neurologic disease burden: difficult but critical</article-title><source>Neurology</source><year>2007</year><volume>68</volume><issue>5</issue><fpage>322</fpage><lpage>323</lpage><pub-id pub-id-type="pmid">17261676</pub-id></element-citation></ref><ref id="bib51"><label>51.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Gowers</surname><given-names>WR</given-names></name></person-group><source>A Manual of the Diseases of the Nervous System</source><year>1902</year><edition>2nd ed</edition><publisher-loc>Philadelphia, PA</publisher-loc><publisher-name>Blakiston</publisher-name></element-citation></ref><ref id="bib52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cummings</surname><given-names>SR</given-names></name></person-group><article-title>Understanding Parkinson disease</article-title><source>JAMA</source><year>1999</year><volume>281</volume><issue>4</issue><fpage>276</fpage><lpage>278</lpage></element-citation></ref><ref id="bib53"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanner</surname><given-names>CM</given-names></name><name><surname>Ottman</surname><given-names>R</given-names></name><name><surname>Goldman</surname><given-names>SM</given-names></name><etal/></person-group><article-title>Parkinson disease in twins: an etiologic study</article-title><source>JAMA</source><year>1999</year><volume>281</volume><issue>4</issue><fpage>341</fpage><lpage>346</lpage><pub-id pub-id-type="pmid">9929087</pub-id></element-citation></ref><ref id="bib54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Payami</surname><given-names>H</given-names></name><name><surname>Zareparsi</surname><given-names>S</given-names></name><name><surname>James</surname><given-names>D</given-names></name><etal/></person-group><article-title>Familial aggregation of Parkinson disease: a comparative study of early-onset and late-onset disease</article-title><source>Arch Neurol</source><year>2002</year><volume>59</volume><issue>5</issue><fpage>848</fpage><lpage>850</lpage><pub-id pub-id-type="pmid">12020270</pub-id></element-citation></ref><ref id="bib55"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Foltynie</surname><given-names>T</given-names></name><name><surname>Sawcer</surname><given-names>S</given-names></name><name><surname>Brayne</surname><given-names>C</given-names></name><etal/></person-group><article-title>The genetic basis of Parkinson's disease</article-title><source>J Neurol Neurosurg Psychiatry</source><year>2002</year><volume>73</volume><issue>4</issue><fpage>363</fpage><lpage>370</lpage><pub-id pub-id-type="pmid">12235301</pub-id></element-citation></ref><ref id="bib56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>EK</given-names></name><name><surname>Skipper</surname><given-names>LM</given-names></name></person-group><article-title>Pathogenic mutations in Parkinson disease</article-title><source>Hum Mutat</source><year>2007</year><volume>28</volume><issue>7</issue><fpage>641</fpage><lpage>653</lpage><pub-id pub-id-type="pmid">17385668</pub-id></element-citation></ref><ref id="bib57"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klein</surname><given-names>C</given-names></name><name><surname>Schlossmacher</surname><given-names>MG</given-names></name></person-group><article-title>Parkinson disease, 10 years after its genetic revolution: multiple clues to a complex disorder</article-title><source>Neurology</source><year>2007</year><volume>69</volume><issue>22</issue><fpage>2093</fpage><lpage>2104</lpage><pub-id pub-id-type="pmid">17761553</pub-id></element-citation></ref><ref id="bib58"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Belin</surname><given-names>AC</given-names></name><name><surname>Westerlund</surname><given-names>M</given-names></name></person-group><article-title>Parkinson's disease: a genetic perspective</article-title><source>FEBS J</source><year>2008</year><volume>275</volume><issue>7</issue><fpage>1377</fpage><lpage>1383</lpage><pub-id pub-id-type="pmid">18279377</pub-id></element-citation></ref><ref id="bib59"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lesage</surname><given-names>S</given-names></name><name><surname>Brice</surname><given-names>A</given-names></name></person-group><article-title>Parkinson's disease: from monogenic forms to genetic susceptibility factors</article-title><source>Hum Mol Genet.</source><year>2009</year><volume>18</volume><issue>R1</issue><fpage>R48</fpage><lpage>R59</lpage><pub-id pub-id-type="pmid">19297401</pub-id></element-citation></ref><ref id="bib60"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Polymeropoulos</surname><given-names>MH</given-names></name><name><surname>Lavedan</surname><given-names>C</given-names></name><name><surname>Leroy</surname><given-names>E</given-names></name><etal/></person-group><article-title>Mutation in the alpha-synuclein gene identified in families with Parkinson's disease</article-title><source>Science</source><year>1997</year><volume>276</volume><issue>5321</issue><fpage>2045</fpage><lpage>2047</lpage><pub-id pub-id-type="pmid">9197268</pub-id></element-citation></ref><ref id="bib61"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pais&#x000e1;n-Ru&#x000ed;z</surname><given-names>C</given-names></name><name><surname>Lang</surname><given-names>AE</given-names></name><name><surname>Kawarai</surname><given-names>T</given-names></name><etal/></person-group><article-title><italic>LRRK2</italic> gene in Parkinson disease: mutation analysis and case control association study</article-title><source>Neurology</source><year>2005</year><volume>65</volume><issue>5</issue><fpage>696</fpage><lpage>700</lpage><pub-id pub-id-type="pmid">16157901</pub-id></element-citation></ref><ref id="bib62"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zimprich</surname><given-names>A</given-names></name><name><surname>Biskup</surname><given-names>S</given-names></name><name><surname>Leitner</surname><given-names>P</given-names></name><etal/></person-group><article-title>Mutations in <italic>LRRK2</italic> cause autosomal-dominant parkinsonism with pleomorphic pathology</article-title><source>Neuron</source><year>2004</year><volume>44</volume><issue>4</issue><fpage>601</fpage><lpage>607</lpage><pub-id pub-id-type="pmid">15541309</pub-id></element-citation></ref><ref id="bib63"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kitada</surname><given-names>T</given-names></name><name><surname>Asakawa</surname><given-names>S</given-names></name><name><surname>Hattori</surname><given-names>N</given-names></name><etal/></person-group><article-title>Mutations in the <italic>parkin</italic> gene cause autosomal recessive juvenile parkinsonism</article-title><source>Nature</source><year>1998</year><volume>392</volume><issue>6676</issue><fpage>605</fpage><lpage>608</lpage><pub-id pub-id-type="pmid">9560156</pub-id></element-citation></ref><ref id="bib64"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonifati</surname><given-names>V</given-names></name><name><surname>Rizzu</surname><given-names>P</given-names></name><name><surname>van Baren</surname><given-names>MJ</given-names></name><etal/></person-group><article-title>Mutations in the <italic>DJ-1</italic> gene associated with autosomal recessive early-onset parkinsonism</article-title><source>Science</source><year>2003</year><volume>299</volume><issue>5604</issue><fpage>256</fpage><lpage>259</lpage><pub-id pub-id-type="pmid">12446870</pub-id></element-citation></ref><ref id="bib65"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valente</surname><given-names>EM</given-names></name><name><surname>Abou-Sleiman</surname><given-names>PM</given-names></name><name><surname>Caputo</surname><given-names>V</given-names></name><etal/></person-group><article-title>Hereditary early-onset Parkinson's disease caused by mutations in <italic>PINK1</italic></article-title><source>Science</source><year>2004</year><volume>304</volume><issue>5674</issue><fpage>1158</fpage><lpage>1160</lpage><pub-id pub-id-type="pmid">15087508</pub-id></element-citation></ref><ref id="bib66"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramirez</surname><given-names>A</given-names></name><name><surname>Heimbach</surname><given-names>A</given-names></name><name><surname>Gr&#x000fc;ndemann</surname><given-names>J</given-names></name><etal/></person-group><article-title>Hereditary parkinsonism with dementia is caused by mutations in <italic>ATP13A2</italic>, encoding a lysosomal type 5 P-type ATPase</article-title><source>Nat Genet.</source><year>2006</year><volume>38</volume><issue>10</issue><fpage>1184</fpage><lpage>1191</lpage><pub-id pub-id-type="pmid">16964263</pub-id></element-citation></ref><ref id="bib67"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gasser</surname><given-names>T</given-names></name><name><surname>M&#x000fc;ller-Myhsok</surname><given-names>B</given-names></name><name><surname>Wszolek</surname><given-names>ZK</given-names></name><etal/></person-group><article-title>A susceptibility locus for Parkinson's disease maps to chromosome 2p13</article-title><source>Nat Genet.</source><year>1998</year><volume>18</volume><issue>3</issue><fpage>262</fpage><lpage>265</lpage><pub-id pub-id-type="pmid">9500549</pub-id></element-citation></ref><ref id="bib68"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hicks</surname><given-names>AA</given-names></name><name><surname>P&#x000e9;tursson</surname><given-names>H</given-names></name><name><surname>J&#x000f3;nsson</surname><given-names>T</given-names></name><etal/></person-group><article-title>A susceptibility gene for late-onset idiopathic Parkinson's disease</article-title><source>Ann Neurol</source><year>2002</year><volume>52</volume><issue>5</issue><fpage>549</fpage><lpage>555</lpage><pub-id pub-id-type="pmid">12402251</pub-id></element-citation></ref><ref id="bib69"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>YJ</given-names></name><name><surname>Scott</surname><given-names>WK</given-names></name><name><surname>Hedges</surname><given-names>DJ</given-names></name><etal/></person-group><article-title>Age at onset in two common neurodegenerative diseases is genetically controlled</article-title><source>Am J Hum Genet.</source><year>2002</year><volume>70</volume><issue>4</issue><fpage>985</fpage><lpage>993</lpage><pub-id pub-id-type="pmid">11875758</pub-id></element-citation></ref><ref id="bib70"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pankratz</surname><given-names>N</given-names></name><name><surname>Nichols</surname><given-names>WC</given-names></name><name><surname>Uniacke</surname><given-names>SK</given-names></name><etal/></person-group><article-title>Genome-wide linkage analysis and evidence of gene-by-gene interactions in a sample of 362 multiplex Parkinson disease families</article-title><source>Hum Mol Genet.</source><year>2003</year><volume>12</volume><issue>20</issue><fpage>2599</fpage><lpage>2608</lpage><pub-id pub-id-type="pmid">12925570</pub-id></element-citation></ref><ref id="bib71"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>M</given-names></name><name><surname>Mueller</surname><given-names>JC</given-names></name><name><surname>Zimprich</surname><given-names>A</given-names></name><etal/></person-group><article-title>The sepiapterin reductase gene region reveals association in the PARK3 locus: analysis of familial and sporadic Parkinson's disease in European populations</article-title><source>J Med Genet.</source><year>2006</year><volume>43</volume><issue>7</issue><fpage>557</fpage><lpage>562</lpage><pub-id pub-id-type="pmid">16443856</pub-id></element-citation></ref><ref id="bib72"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klein</surname><given-names>C</given-names></name><name><surname>Lohmann-Hedrich</surname><given-names>K</given-names></name></person-group><article-title>Impact of recent genetic findings in Parkinson's disease</article-title><source>Curr Opin Neurol</source><year>2007</year><volume>20</volume><issue>4</issue><fpage>453</fpage><lpage>464</lpage><pub-id pub-id-type="pmid">17620882</pub-id></element-citation></ref><ref id="bib73"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maraganore</surname><given-names>DM</given-names></name><name><surname>de Andrade</surname><given-names>M</given-names></name><name><surname>Lesnick</surname><given-names>TG</given-names></name><etal/></person-group><article-title>High-resolution whole-genome association study of Parkinson disease</article-title><source>Am J Hum Genet.</source><year>2005</year><volume>77</volume><issue>5</issue><fpage>685</fpage><lpage>693</lpage><pub-id pub-id-type="pmid">16252231</pub-id></element-citation></ref><ref id="bib74"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freedman</surname><given-names>ML</given-names></name><name><surname>Reich</surname><given-names>D</given-names></name><name><surname>Penney</surname><given-names>KL</given-names></name><etal/></person-group><article-title>Assessing the impact of population stratification on genetic association studies</article-title><source>Nat Genet.</source><year>2004</year><volume>36</volume><issue>4</issue><fpage>388</fpage><lpage>393</lpage><pub-id pub-id-type="pmid">15052270</pub-id></element-citation></ref><ref id="bib75"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pankratz</surname><given-names>N</given-names></name><name><surname>Wilk</surname><given-names>JB</given-names></name><name><surname>Latourelle</surname><given-names>JC</given-names></name><etal/></person-group><article-title>Genomewide association study for susceptibility genes contributing to familial Parkinson disease</article-title><source>Hum Genet.</source><year>2009</year><volume>124</volume><issue>6</issue><fpage>593</fpage><lpage>605</lpage><pub-id pub-id-type="pmid">18985386</pub-id></element-citation></ref><ref id="bib76"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Evangelou</surname><given-names>E</given-names></name><name><surname>Maraganore</surname><given-names>DM</given-names></name><name><surname>Ioannidis</surname><given-names>JP</given-names></name></person-group><article-title>Meta-analysis in genome-wide association datasets: strategies and application in Parkinson disease [electronic article]</article-title><source>PLoS One</source><year>2007</year><volume>2</volume><issue>2</issue><fpage>e196</fpage><pub-id pub-id-type="pmid">17332845</pub-id></element-citation></ref><ref id="bib77"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clarimon</surname><given-names>J</given-names></name><name><surname>Scholz</surname><given-names>S</given-names></name><name><surname>Fung</surname><given-names>HC</given-names></name><etal/></person-group><article-title>Conflicting results regarding the semaphorin gene (<italic>SEMA5A</italic>) and the risk for Parkinson disease</article-title><source>Am J Hum Genet.</source><year>2006</year><volume>78</volume><issue>6</issue><fpage>1082</fpage><lpage>1084</lpage><comment>author reply 1092&#x02013;1094</comment><pub-id pub-id-type="pmid">16685660</pub-id></element-citation></ref><ref id="bib78"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farrer</surname><given-names>MJ</given-names></name><name><surname>Haugarvoll</surname><given-names>K</given-names></name><name><surname>Ross</surname><given-names>OA</given-names></name><etal/></person-group><article-title>Genomewide association, Parkinson disease, and PARK10</article-title><source>Am J Hum Genet.</source><year>2006</year><volume>78</volume><issue>6</issue><fpage>1084</fpage><lpage>1088</lpage><comment>author reply 1092&#x02013;1094</comment><pub-id pub-id-type="pmid">16685661</pub-id></element-citation></ref><ref id="bib79"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goris</surname><given-names>A</given-names></name><name><surname>Williams-Gray</surname><given-names>CH</given-names></name><name><surname>Foltynie</surname><given-names>T</given-names></name><etal/></person-group><article-title>No evidence for association with Parkinson disease for 13 single-nucleotide polymorphisms identified by whole-genome association screening</article-title><source>Am J Hum Genet.</source><year>2006</year><volume>78</volume><issue>6</issue><fpage>1088</fpage><lpage>1090</lpage><pub-id pub-id-type="pmid">16685662</pub-id></element-citation></ref><ref id="bib80"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elbaz</surname><given-names>A</given-names></name><name><surname>Nelson</surname><given-names>LM</given-names></name><name><surname>Payami</surname><given-names>H</given-names></name><etal/></person-group><article-title>Lack of replication of thirteen single-nucleotide polymorphisms implicated in Parkinson's disease: a large-scale international study</article-title><source>Lancet Neurol</source><year>2006</year><volume>5</volume><issue>11</issue><fpage>917</fpage><lpage>923</lpage><pub-id pub-id-type="pmid">17052658</pub-id></element-citation></ref><ref id="bib81"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Lau</surname><given-names>LM</given-names></name><name><surname>Breteler</surname><given-names>MM</given-names></name></person-group><article-title>Epidemiology of Parkinson's disease</article-title><source>Lancet Neurol</source><year>2006</year><volume>5</volume><issue>6</issue><fpage>525</fpage><lpage>535</lpage><pub-id pub-id-type="pmid">16713924</pub-id></element-citation></ref><ref id="bib82"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hancock</surname><given-names>DB</given-names></name><name><surname>Martin</surname><given-names>ER</given-names></name><name><surname>Mayhew</surname><given-names>GM</given-names></name><etal/></person-group><article-title>Pesticide exposure and risk of Parkinson's disease: a family-based case-control study [electronic article]</article-title><source>BMC Neurol</source><year>2008</year><volume>8</volume><fpage>6</fpage><pub-id pub-id-type="pmid">18373838</pub-id></element-citation></ref><ref id="bib83"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Powers</surname><given-names>KM</given-names></name><name><surname>Kay</surname><given-names>DM</given-names></name><name><surname>Factor</surname><given-names>SA</given-names></name><etal/></person-group><article-title>Combined effects of smoking, coffee, and NSAIDs on Parkinson's disease risk</article-title><source>Mov Disord</source><year>2008</year><volume>23</volume><issue>1</issue><fpage>88</fpage><lpage>95</lpage><pub-id pub-id-type="pmid">17987647</pub-id></element-citation></ref><ref id="bib84"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCulloch</surname><given-names>CC</given-names></name><name><surname>Kay</surname><given-names>DM</given-names></name><name><surname>Factor</surname><given-names>SA</given-names></name><etal/></person-group><article-title>Exploring gene-environment interactions in Parkinson's disease</article-title><source>Hum Genet.</source><year>2008</year><volume>123</volume><issue>3</issue><fpage>257</fpage><lpage>265</lpage><pub-id pub-id-type="pmid">18210157</pub-id></element-citation></ref><ref id="bib85"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gorell</surname><given-names>JM</given-names></name><name><surname>Johnson</surname><given-names>CC</given-names></name><name><surname>Rybicki</surname><given-names>BA</given-names></name><etal/></person-group><article-title>The risk of Parkinson's disease with exposure to pesticides, farming, well water, and rural living</article-title><source>Neurology</source><year>1998</year><volume>50</volume><issue>5</issue><fpage>1346</fpage><lpage>1350</lpage><pub-id pub-id-type="pmid">9595985</pub-id></element-citation></ref><ref id="bib86"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Priyadarshi</surname><given-names>A</given-names></name><name><surname>Khuder</surname><given-names>SA</given-names></name><name><surname>Schaub</surname><given-names>EA</given-names></name><etal/></person-group><article-title>Environmental risk factors and Parkinson's disease: a metaanalysis</article-title><source>Environ Res.</source><year>2001</year><volume>86</volume><issue>2</issue><fpage>122</fpage><lpage>127</lpage><pub-id pub-id-type="pmid">11437458</pub-id></element-citation></ref><ref id="bib87"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ascherio</surname><given-names>A</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Weisskopf</surname><given-names>MG</given-names></name><etal/></person-group><article-title>Pesticide exposure and risk for Parkinson's disease</article-title><source>Ann Neurol</source><year>2006</year><volume>60</volume><issue>2</issue><fpage>197</fpage><lpage>203</lpage><pub-id pub-id-type="pmid">16802290</pub-id></element-citation></ref><ref id="bib88"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamel</surname><given-names>F</given-names></name><name><surname>Tanner</surname><given-names>CM</given-names></name><name><surname>Umbach</surname><given-names>DM</given-names></name><etal/></person-group><article-title>Pesticide exposure and self-reported Parkinson's disease in the Agricultural Health Study</article-title><source>Am J Epidemiol</source><year>2007</year><volume>165</volume><issue>4</issue><fpage>364</fpage><lpage>374</lpage><pub-id pub-id-type="pmid">17116648</pub-id></element-citation></ref><ref id="bib89"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frigerio</surname><given-names>R</given-names></name><name><surname>Elbaz</surname><given-names>A</given-names></name><name><surname>Sanft</surname><given-names>KR</given-names></name><etal/></person-group><article-title>Education and occupations preceding Parkinson disease: a population-based case-control study</article-title><source>Neurology</source><year>2005</year><volume>65</volume><issue>10</issue><fpage>1575</fpage><lpage>1583</lpage><pub-id pub-id-type="pmid">16301484</pub-id></element-citation></ref><ref id="bib90"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shulman</surname><given-names>LM</given-names></name></person-group><article-title>Is there a connection between estrogen and Parkinson's disease?</article-title><source>Parkinsonism Relat Disord</source><year>2002</year><volume>8</volume><issue>5</issue><fpage>289</fpage><lpage>295</lpage><pub-id pub-id-type="pmid">15177058</pub-id></element-citation></ref><ref id="bib91"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maraganore</surname><given-names>DM</given-names></name><name><surname>Lesnick</surname><given-names>TG</given-names></name><name><surname>Elbaz</surname><given-names>A</given-names></name><etal/></person-group><article-title><italic>UCHL1</italic> is a Parkinson's disease susceptibility gene</article-title><source>Ann Neurol</source><year>2004</year><volume>55</volume><issue>4</issue><fpage>512</fpage><lpage>521</lpage><pub-id pub-id-type="pmid">15048890</pub-id></element-citation></ref><ref id="bib92"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Facheris</surname><given-names>M</given-names></name><name><surname>Strain</surname><given-names>KJ</given-names></name><name><surname>Lesnick</surname><given-names>TG</given-names></name><etal/></person-group><article-title>UCHL1 is associated with Parkinson's disease: a case-unaffected sibling and case-unrelated control study</article-title><source>Neurosci Lett.</source><year>2005</year><volume>381</volume><issue>1-2</issue><fpage>131</fpage><lpage>134</lpage><pub-id pub-id-type="pmid">15882803</pub-id></element-citation></ref><ref id="bib93"><label>93.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Petitti</surname><given-names>D</given-names></name></person-group><source>Meta-analysis, Decision Analysis, and Cost-effectiveness Analysis: Methods for Quantitative Synthesis in Medicine</source><year>1994</year><publisher-loc>New York, NY</publisher-loc><publisher-name>Oxford University Press</publisher-name></element-citation></ref><ref id="bib94"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Higgins</surname><given-names>JP</given-names></name><name><surname>Thompson</surname><given-names>SG</given-names></name><name><surname>Deeks</surname><given-names>JJ</given-names></name><etal/></person-group><article-title>Measuring inconsistency in meta-analyses</article-title><source>BMJ</source><year>2003</year><volume>327</volume><issue>7414</issue><fpage>557</fpage><lpage>560</lpage><pub-id pub-id-type="pmid">12958120</pub-id></element-citation></ref><ref id="bib95"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hutter</surname><given-names>CM</given-names></name><name><surname>Samii</surname><given-names>A</given-names></name><name><surname>Factor</surname><given-names>SA</given-names></name><etal/></person-group><article-title>Lack of evidence for an association between <italic>UCHL1</italic> S18Y and Parkinson's disease</article-title><source>Eur J Neurol</source><year>2008</year><volume>15</volume><issue>2</issue><fpage>134</fpage><lpage>139</lpage><pub-id pub-id-type="pmid">18093156</pub-id></element-citation></ref><ref id="bib96"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gasser</surname><given-names>T</given-names></name><name><surname>Pilz</surname><given-names>P</given-names></name><name><surname>Omasmeier</surname><given-names>D</given-names></name><etal/></person-group><article-title>Ubiquitin C-terminal hydrolase L1 in sporadic Parkinson's disease [abstract]</article-title><source>Mov Disord</source><year>2000</year><fpage>A201</fpage></element-citation></ref><ref id="bib97"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elbaz</surname><given-names>A</given-names></name><name><surname>Levecque</surname><given-names>C</given-names></name><name><surname>Clavel</surname><given-names>J</given-names></name><etal/></person-group><article-title>S18Y polymorphism in the <italic>UCH-L1</italic> gene and Parkinson's disease: evidence for an age-dependent relationship</article-title><source>Mov Disord</source><year>2003</year><volume>18</volume><issue>2</issue><fpage>130</fpage><lpage>137</lpage><pub-id pub-id-type="pmid">12539205</pub-id></element-citation></ref><ref id="bib98"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Zhao</surname><given-names>CY</given-names></name><name><surname>Si</surname><given-names>YM</given-names></name><etal/></person-group><article-title><italic>ACT</italic> and <italic>UCH-L1</italic> polymorphisms in Parkinson's disease and age of onset</article-title><source>Mov Disord</source><year>2002</year><volume>17</volume><issue>4</issue><fpage>767</fpage><lpage>771</lpage><pub-id pub-id-type="pmid">12210873</pub-id></element-citation></ref><ref id="bib99"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carmine Belin</surname><given-names>A</given-names></name><name><surname>Westerlund</surname><given-names>M</given-names></name><name><surname>Bergman</surname><given-names>O</given-names></name><etal/></person-group><article-title>S18Y in ubiquitin carboxy-terminal hydrolase L1 (<italic>UCH-L1</italic>) associated with decreased risk of Parkinson's disease in Sweden</article-title><source>Parkinsonism Relat Disord</source><year>2007</year><volume>13</volume><issue>5</issue><fpage>295</fpage><lpage>298</lpage><pub-id pub-id-type="pmid">17287139</pub-id></element-citation></ref><ref id="bib100"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mellick</surname><given-names>GD</given-names></name><name><surname>Silburn</surname><given-names>PA</given-names></name></person-group><article-title>The ubiquitin carboxy-terminal hydrolase-L1 gene S18Y polymorphism does not confer protection against idiopathic Parkinson's disease</article-title><source>Neurosci Lett.</source><year>2000</year><volume>293</volume><issue>2</issue><fpage>127</fpage><lpage>130</lpage><pub-id pub-id-type="pmid">11027850</pub-id></element-citation></ref><ref id="bib101"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levecque</surname><given-names>C</given-names></name><name><surname>Dest&#x000e9;e</surname><given-names>A</given-names></name><name><surname>Mouroux</surname><given-names>V</given-names></name><etal/></person-group><article-title>No genetic association of the ubiquitin carboxy-terminal hydrolase-L1 gene S18Y polymorphism with familial Parkinson's disease</article-title><source>J Neural Transm</source><year>2001</year><volume>108</volume><issue>8-9</issue><fpage>979</fpage><lpage>984</lpage><pub-id pub-id-type="pmid">11716150</pub-id></element-citation></ref><ref id="bib102"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Savettieri</surname><given-names>G</given-names></name><name><surname>De Marco</surname><given-names>EV</given-names></name><name><surname>Civitelli</surname><given-names>D</given-names></name><etal/></person-group><article-title>Lack of association between ubiquitin carboxy-terminal hydrolase L1 gene polymorphism and PD</article-title><source>Neurology</source><year>2001</year><volume>57</volume><issue>3</issue><fpage>560</fpage><lpage>561</lpage><pub-id pub-id-type="pmid">11502942</pub-id></element-citation></ref><ref id="bib103"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maraganore</surname><given-names>DM</given-names></name><name><surname>de Andrade</surname><given-names>M</given-names></name><name><surname>Lesnick</surname><given-names>TG</given-names></name><etal/></person-group><article-title>Complex interactions in Parkinson's disease: a two-phased approach</article-title><source>Mov Disord</source><year>2003</year><volume>18</volume><issue>6</issue><fpage>631</fpage><lpage>636</lpage><pub-id pub-id-type="pmid">12784265</pub-id></element-citation></ref><ref id="bib104"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ioannidis</surname><given-names>JP</given-names></name><name><surname>Boffetta</surname><given-names>P</given-names></name><name><surname>Little</surname><given-names>J</given-names></name><etal/></person-group><article-title>Assessment of cumulative evidence on genetic associations: interim guidelines</article-title><source>Int J Epidemiol</source><year>2008</year><volume>37</volume><issue>1</issue><fpage>120</fpage><lpage>132</lpage><pub-id pub-id-type="pmid">17898028</pub-id></element-citation></ref><ref id="bib105"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Setsuie</surname><given-names>R</given-names></name><name><surname>Wada</surname><given-names>K</given-names></name></person-group><article-title>The functions of UCH-L1 and its relation to neurodegenerative diseases</article-title><source>Neurochem Int</source><year>2007</year><volume>51</volume><issue>2-4</issue><fpage>105</fpage><lpage>111</lpage><pub-id pub-id-type="pmid">17586089</pub-id></element-citation></ref><ref id="bib106"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mizuta</surname><given-names>I</given-names></name><name><surname>Satake</surname><given-names>W</given-names></name><name><surname>Nakabayashi</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Multiple candidate gene analysis identifies alpha-synuclein as a susceptibility gene for sporadic Parkinson's disease</article-title><source>Hum Mol Genet.</source><year>2006</year><volume>15</volume><issue>7</issue><fpage>1151</fpage><lpage>1158</lpage><pub-id pub-id-type="pmid">16500997</pub-id></element-citation></ref><ref id="bib107"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Momose</surname><given-names>Y</given-names></name><name><surname>Murata</surname><given-names>M</given-names></name><name><surname>Kobayashi</surname><given-names>K</given-names></name><etal/></person-group><article-title>Association studies of multiple candidate genes for Parkinson's disease using single nucleotide polymorphisms</article-title><source>Ann Neurol</source><year>2002</year><volume>51</volume><issue>1</issue><fpage>133</fpage><lpage>136</lpage><pub-id pub-id-type="pmid">11782995</pub-id></element-citation></ref><ref id="bib108"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Hattori</surname><given-names>N</given-names></name><name><surname>Leroy</surname><given-names>E</given-names></name><etal/></person-group><article-title>Association between a polymorphism of ubiquitin carboxy-terminal hydrolase L1 (<italic>UCH-L1</italic>) gene and sporadic Parkinson's disease</article-title><source>Parkinsonism Relat Disord</source><year>2000</year><volume>6</volume><issue>4</issue><fpage>195</fpage><lpage>197</lpage><pub-id pub-id-type="pmid">10900392</pub-id></element-citation></ref><ref id="bib109"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>EK</given-names></name><name><surname>Puong</surname><given-names>KY</given-names></name><name><surname>Fook-Chong</surname><given-names>S</given-names></name><etal/></person-group><article-title>Case-control study of <italic>UCHL1</italic> S18Y variant in Parkinson's disease</article-title><source>Mov Disord</source><year>2006</year><volume>21</volume><issue>10</issue><fpage>1765</fpage><lpage>1768</lpage><pub-id pub-id-type="pmid">16941465</pub-id></element-citation></ref></ref-list></back></article>